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Abstract
 Biological entities such as genes, promoters, mRNA,Background:
metabolites or proteins do not act alone, but in concert in their network
context. Modules, i.e., groups of nodes with similar topological properties in
these networks characterize important biological functions of the underlying
biomolecular system. Edges in such molecular networks represent
regulatory and physical interactions, and comparing them between
conditions provides valuable information on differential molecular
mechanisms. However, biological data is inherently noisy and network
reduction techniques can propagate errors particularly to the level of edges.
We aim to improve the analysis of networks of biological molecules by
deriving modules together with edge relevance estimations that are based
on global network characteristics.
The key challenge we address here is investigating the capabilityMethods: 
of stochastic block models (SBMs) for representing and analyzing different
types of biomolecular networks. Fitting them to SBMs both delivers
modules of the networks and enables the derivation of edge confidence
scores, and it has not yet been investigated for analyzing biomolecular
networks. We apply SBM-based analysis independently to three
correlation-based networks of breast cancer data originating from
high-throughput measurements of different molecular layers: either
transcriptomics, proteomics, or metabolomics. The networks were reduced
by thresholding for correlation significance or by requirements on
scale-freeness. 
 We find that the networks are best representedResults and discussion:
by the hierarchical version of the SBM, and many of the predicted blocks
have a biologically and phenotypically relevant functional annotation. The
edge confidence scores are overall in concordance with the biological
evidence given by the measurements. We conclude that biomolecular
networks can be appropriately represented and analyzed by fitting SBMs.
As the SBM-derived edge confidence scores are based on global network
connectivity characteristics and potential hierarchies within the
biomolecular networks are considered, they could be used as additional,
integrated features in network-based data comparisons.
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Introduction
High-throughput measurement techniques are advancing and 
become ever less expensive, enabling the screening of multiple 
biological data layers in single patients as almost standard 
clinical diagnostic tools. The wealth of the biological data can 
only be understood if treating the measured entities – gene 
promotors, mRNA, metabolites, proteins and their activity – not 
separately, but in their network context1. Thereby, one method 
to capture the interdependencies of the intracellular machinery 
relies on the hypothesis that strongly connected molecular 
entities are either co-activated or co-repressed, i.e. their measured 
abundances should be correlated2–4. Fully connected, weighted 
biomolecular networks can be established, in which each node 
corresponds to a molecular entity and is connected to each 
other node by an edge. The weight of the edge is the correla-
tion between the measurements and is considered to represent 
how strongly the nodes are connected, interact or regulate each 
other.
Approaching a network-level analysis of a biological system 
by correlation-based interactions has the advantage that it does 
not require a priori knowledge, and thus it is focused on the 
interaction profile for which evidence can be found in the 
measurements of the considered condition. However, this is a 
blessing and a curse: correlation-based networks suffer from the 
fact that the biological measurements are inherently noisy, 
even more so for small sample sizes as in rare diseases or in 
personalized medicine. This affects the values of the edge 
weights and the results of network reduction, and can be del-
eterious for subsequent analyses of the networks. In these cases, 
considering in addition alternative sources of edge relevance 
that are based on more global characteristics of the system 
might be beneficial and could make the network representations 
of the system and their analysis more robust.
One of the commonly performed analyses of correlation-based 
networks relies on the observation that biological networks 
exhibit a modular structure, in which tightly regulated modules 
are loosely connected to other modules. An important readout 
from correlation-based networks therefore is the biological and 
functional characterization of condition-specific modules, i.e. 
communities of co-regulated entities. A plethora of methods for 
module detection in networks has been proposed5–14. Also for the 
inference of edge relevance, or edge prediction, as being tightly 
linked to the problem of the detection of missing or spurious 
edges, numerous methods have been suggested15–23. In this work, 
we showcase a method that is able to derive, within a single 
framework, modules as well as scores of edge relevance: 
representing the biomolecular correlation-based networks as 
stochastic block models (SBMs)24.
SBMs are the simplest form of generative network models for 
community structures and can also accommodate hierarchies25, 
which are key to convey robustness to biological function. Other 
generative model approaches relying on scale-freeness of the 
network architecture have been used for edge prediction in 
protein-protein interaction networks15, and the SBM has been 
used for representing other types of networks17,18,26,27, but not yet 
for biomolecular networks. In generative network model 
approaches, the network is described by a stringent mathematical 
framework based on statistical assumptions on network char-
acteristics. For the case of the stochastic block model, this 
step delivers already the modular structure of the network as 
the nodes are assigned to blocks according to their connectivity 
properties to all other nodes. In contrast to other module detec-
tion methods, blocks in the SBM are not necessarily formed by 
tightly intra-connected entities but by entities which inter-
act similarly with the nodes from all other blocks. Therefore, 
comparing SBM-derived modules between networks represent-
ing different (e.g. biomedical) conditions could be especially 
informative to shed light on regulatory changes. In a second step, 
the mathematical representation of the networks by SBMs is 
exploited to estimate edge probabilities. Specifically, it is assessed 
whether the existence of an edge in the network improves or 
reduces the fit of the network to the SBM. The resulting edge 
confidence scores are based on global network structure and can 
be used as alternative measure of edge relevance.
The key challenge we address here was to investigate the 
capability of SBMs for representing and analyzing different types 
of biomolecular networks. We aimed to assess to which extent 
the SBM is applicable to derive useful information in terms 
of (i) relevant clustering as well as (ii) network-based, alterna-
tive edge scores. Therefore, we showcased the SBM-based anal-
ysis (overview in Figure 1A) for three biomolecular networks of 
different molecular types, derived from either transcriptomic, 
            Amendments from Version 1
In the revised version of our manuscript, we reformulated parts 
of the Abstract and Introduction in order to clarify the goal of our 
analysis: Assessing whether stochastic block models (SBMs) 
can be used to represent and analyze single-layer biomolecular 
networks derived from different, clinically relevant datatypes that 
provide complementary perspectives of cellular or tumour tissue 
properties. 
We included a more detailed description of the network reduction 
procedures and the applied reasoning in the Methods and 
Results sections, along with new Figure 1D, as well as the 
relationship between the two employed reduction methods in new 
Figure S1. We incorporated a description of the SBM types and 
their associated formalisms that connect them to the properties of 
the modelled network into the Methods section. 
We clarified the contents of Figure 3 by adapting its description 
and shifting contents to new Figure S3, and we included pathway 
distances of the higher-level blocks (new Figure 3D). 
The most comprehensive extensions consist of new analyses 
with a focus on biological predictions. First, we compare 
biological insights derived from SBM-based clustering to known 
characteristics of breast cancer, that is the phenotype we employ 
for our case study, as derived from MSigDB (new Figure 4). 
Second, we summarize predictions of the SBM-based clustering 
(new Figure 5, new Table 2) and relate them to (breast) cancer 
literature. Together with the strikingly tight relationship between 
SBM-based edge scores and data-derived edge interaction 
strength (correlation), these analyses support our conclusion 
that SBMs are suitable to represent and analyze biomolecular 
networks and to derive relevant predictions.
Any further responses from the reviewers can be found at the 
end of the article.
REVISED
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Figure  1.  Analysis  of  correlation-based  networks  from  different  omics  data:  Pipeline  and  network  preparation.  (A) Pipeline 
for the approach. Given the matrix of measurements of mRNA expression, protein expression or metabolite abundance for a group of 
samples (I), we compute a fully-connected weighted network (II) of the molecular species for each data layer separately using a correlation-
based approach. We reduce the networks by setting a threshold to the edge weights and binarize the networks (III). Each network is fitted 
to different types of stochastic block models in which the network nodes are partitioned into blocks (IV), the best fitting model is employed 
for deriving SBM-based edge confidence scores (V). (B) We established correlation-based networks using Spearman’s correlation within 
mRNA expression, protein expression and metabolite biomolecular data from a subgroup of cancer patients. Shown are histograms of the 
correlations obtained for all edges of the networks. (C) We only kept edges in the network that had a correlation which differed significantly 
from zero (sign. corr.). For different multiple testing correction methods (BH: Benjamini-Hochberg, BF: Bonferroni) and significance levels 
(0.05, 0.01), different degrees of reduction can be achieved. We chose for each data layer the most stringent threshold (highlighted in 
blue) that reduced the edge count to less than 107 edges (left) while keeping the percentage of nodes in the largest connected component 
high (right). (D) Scale-free fit indices R2 according to 3 for the mRNA (green), protein (blue), and metabolite (red) network reduced by 
different correlation thresholds between 0.3 and 0.95. The employed threshold of 0.85 for the scale-free fit index is indicated by a black line. 
(E) Histogram of the node degrees of the networks reduced by criterion on significance of correlation (red) or on scale-freeness (blue) on 
double log-scale together with the scale-free fit indices R2. Networks are the more scale-free the more linear the relationship between log-
frequency and log-node-degree is.
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proteomic or metabolomics data of breast cancer tumours. 
We assessed which of the different versions of SBM fits each 
data layer best. Then, we investigated whether the SBM repre-
sentation is able to capture functionally relevant structures in our 
biomolecular networks. In detail, we determined the agreement 
between the predicted blocks and independent biomolecular func-
tional annotations from databases, compared the SBM-predicted 
function to breast cancer signatures and showed how to derive 
additional predictions from SBM-based clusters. Finally, we took 
advantage of the description of the networks as SBMs for the 
computation of an edge confidence score for each edge as 
measure of edge relevance. The edge confidence scores can be 
exploited to re-establish erroneously removed edges or to 
remove spurious edges, or they could serve by themselves for 
deriving disease-relevant differences when comparing groups of 
patients.
All code is freely available on https://gitlab.com/biomodlih/sbm-
for-correlation-based-networks.
Methods
mRNA, protein, metabolite data for ER- breast cancer 
tumors
Breast cancer mRNA expression from RNAseq was obtained 
from the TCGA BRCA cohort via RTCGA28 downloading 
TCGA level 3 preprocessed BRCA files (search term: mRNAseq_ 
Preprocess) on Nov 2, 2017. We used the normalized RSEM 
values. Protein data was obtained via the CPTAC homepage 
from the data generated in 29. We used the first replicate of sam-
ples measured in duplicates. We employed the unshared log 
ratio value for each sample to maximize reliability of protein 
identification. Clinical data for both TCGA and CPTAC data 
was retrieved and evaluated using the RTCGA package. Specifi-
cally, we used the following files for mRNA, protein and clinical 
data, respectively:
•    gdac.broadinstitute.org_BRCA.mRNAseq_Preprocess.
Level_3.2016012800.0.0/ BRCA.uncv2.mRNAseq_RSEM_
normalized_log2.txt
•    TCGA_Breast_BI_Proteome_CDAP_Protein_Report.r3/
Protein_data/CDAP/TCGA_Breast_BI_Proteome.itraq.tsv
•    gdac .broadins t i tu te.org_BRCA.Merge_Cl in ica l . 
Level_1.2016012800.0.0/BRCA.clin.merged.txt.
For both mRNA and protein data, we only used samples from 
patients whose entry “patient.breast_carcinoma_estrogen_ 
receptor_status” in their clinical data was “negative”. In addition, 
we restricted our analysis to solid tumour samples, i.e. TCGA 
sample identifiers ending with 01. This gave rise to 237 samples 
with 18321 measured genes for the mRNA data and 36 samples 
with 10625 measured proteins for the protein data. 
Metabolite data was used from the Excel file provided in 30 
using the measurements of 162 metabolites in the 67 samples 
containing ERn in their label.
Missing values
We removed missing values in the mRNA data by replacing 
them by -10 to account for the fact that they arose from 
logarithmizing read counts of zero. In the protein data, we 
removed the 2195 proteins which had more than 20% of miss-
ing values over the considered samples (i.e. more than 7 NAs 
among the 36 samples), resulting in 8430 measured proteins that 
we analyzed further. The metabolite data did not contain missing 
values as imputation had been performed in the original 
publication30.
Network generation
We used the correlation computation from the Hmisc package31 
(function rcorr) to determine Spearman’s correlation of the 
measurements of each pair of entities (mRNA, protein or 
metabolite) over all samples. Only pairwise complete observa-
tions were employed. Unless stated otherwise, we neglected 
self-edges.
Network reduction
The Hmisc package31 was used to determine the p-value asso-
ciated to the correlation (significance of the correlation being 
different from zero). For each data layer, we assessed four differ-
ent combinations of multiple testing correction and significance 
thresholds: Bonferroni or Benjamini-Hochberg32 multiple test-
ing correction combined with significance thresholds of 0.01 or 
0.05. The resulting reduced networks were characterized in terms 
of edge count and largest connected component. For each data 
layer, the network was chosen that yielded a sufficient degree 
of reduction (< 107 edges) to enable a sufficiently short compu-
tation time and memory consumption for the fit to SBM while 
maintaining at the same time a high percentage of nodes being 
connected to each other as would be expected in biological net-
works. Finally, Bonferroni correction was chosen for the mRNA 
network, Benjamini-Hochberg correction for the smaller pro-
tein and metabolite networks. Correlations were considered sig-
nificantly different from zero for corrected p-values lower than 
0.05 (mRNA, metabolite) or 0.01 (protein).
For the reduction by imposing a scale-free architecture of the 
reduced network, we employed the pickHardThreshold function 
of the WGCNA package3 with the default requirement (0.85) on 
goodness of fit to a power-law degree distribution of the nodes. 
Given the symmetric absolute correlation matrix of the net-
work edges, this function reduces the network by one of a given 
set of edge thresholds at a time and determines the scale-free 
fit index R2 which lies between 0 (bad fit) and 1 (perfect fit) 
by comparing the resulting degree distribution of the reduced 
network to a power-law degree distribution. The lowest of the 
tested edge thresholds that gives a scale-free fit index > 0.85 is 
reported as estimated threshold. For the edge thresholds, we 
started with a grid with stepsize 0.05 between 0.3 and 0.95, refin-
ing according to the resulting estimates to vectors with stepsize 
0.001 between 0.5 and 0.625 for the mRNA network, between 
0.7 and 0.82 for the protein network, and between 0.3 and 0.4 
for the metabolite network. Finally estimated edge correlation 
thresholds were 0.603 (mRNA), 0.788 (protein), and 0.375 
(metabolite).
Fit to SBM
We employed four versions of the stochastic block model 
(SBM) derived from three SBM types (classical, degree-corrected, 
hierarchical SBM) and their Bayesian description33,34. In the 
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classical SBM24, the model is fully defined by a partition b 
of the nodes into blocks and the matrix e = {e
rs
} of the numbers 
of edges between blocks (with e
rr
 being double the edge count 
within a block for convenience). We employ microcanonical for-
mulations which imposes hard constraints on the values of the 
model parameters according to the observed graph G34. Given 
a graph G and a partition b, the probability that the graph 
was generated with the observed edge count matrix e, P(G|b), 
can be described as
                               
( | ) ( ) ( )P G b P G | e,b P e= ⋅ ⋅
Thereby, P(A|C, D) denotes the probability of A given C 
and D. With A = {Aij} being the adjacency matrix of the 
(multi)graph G, with r rsse e= ∑  the number of edges adjacent to 
block r, and n
r
 the number of nodes in block r according to the 
partition b, we employ
                  
( | , )
i
rs rrr s r
er
r j iir i j i
e e
P G e b
n A A
<
<
!!
=
! !!
∏ ∏
∏ ∏ ∏
using the definition (2m)!! = 2m·m!. In addition, for 
n
e
 = 2E/(B(B+1)) the expected total number of edges with E the 
number of edges in graph G, and B the number of non-empty 
blocks in partition b the prior distribution on the edges is given by:
                              
( 1) / 2( ) ( 1)
E
e
E B B
e
n
P e
n
+ += + i
.
Please refer to Peixoto, 201734 for a detailed derivation and 
explanation. Note that for our networks, as we only use sim-
ple graphs and do not consider self-edges, i.e. Aij ∈ {0, 1} 
and Aii = 0, the product ij iii j iA A< ! !!∏ ∏  simplifies to 1. The 
prior for the partition b is derived from sampling the number 
of non-empty blocks B as P(B) = 1/N with N the number of 
nodes in graph G, then sample the distribution of block sizes 
n
r
 conditioned on B and finally the partition b conditioned 
on the former two which yields in total34:
                              
11 1( ) .
1
rr
n N
P b
BN N
−! − =  −!  
∏
A drawback of the classical SBM is that all nodes within a 
block are forced to have similar degrees which is not appropri-
ate for most encountered real networks. Karrer and Newman 
proposed the degree-corrected SBM35 that is, in addition to the 
partition b and the edge count matrix e, defined by a degree 
sequence k = {ki} setting a degree for each node. Using the 
microcanonical formulation34, we have
                    
..( | ) ( | , , ) ( ) ( ).P G b P G k e b k | e,b eP P=
with P(e) as above. P(G|k, e, b) is the probability of generating 
a graph G where the edge counts as well as the degree sequence 
is fixed to a specific value given a certain partition b and is 
given by
                    
( | , , ) .rs r ir s r i
rr
e e r k
P G k e b
e
< ! !! !=
!!
∏ ∏ ∏
∏
The prior we employ for the degree sequence is conditioned 
on the degree frequencies which are in turn sampled from a 
uniform hyperprior34:
                     
1( | , ) ( , )
r
kk
r r
r rr
P k e b q e n
n
η −!=
!
∏∏ ∏
with rkη  the number of nodes of degree k in block r and 
q(n, m) the number of partitions of n elements into at most 
m groups.
The Bayesian approach as detailed by Peixoto33,34 prevents 
overfitting but is prone to underfitting, meaning that statisti-
cally relevant structures may not be detected. In particular, the 
number of groups which can be resolved is limited such that small 
groups in very large networks can hardly be detected34. A solu-
tion has been proposed via the hierarchical (or nested) SBM25. 
Therein, the edge count matrix e = {e
rs
} is described with another 
SBM, i.e. the blocks of the first SBM are considered as nodes 
a second-level SBM which are partitioned into a second level 
of blocks, with the according second-level edge count matrix. 
The second-level SBM can again be described as another third- 
level SBM and so on, L number of times, forming a nested 
hierarchy of SBMs. 
The joint distribution for the hierarchical microcanonical 
degree-corrected SBM is given by34
1 1 1 1( , ,{ },{ }) ( | , , ) ( | , ) ({ }) ({ })l l l lP A k e b P A k e b P k e b P e P b= ⋅ ⋅ ⋅
for l ∈ {0 , . . . ,L}, with el the edge count matrix at level l, 
bl the partition at level l. The according prior distributions are 
given as described above and in addition for the edge count by34
                         
1
1
({ } |{ }) ( | , )
L
l l l l l
l
P e b P e e b+
=
=∏
and imposing the boundary conditions BL = 1 for the number 
of nonempty blocks at the highest level L, and P(bL ) = 1. Thereby,
        
1 1
1 1 1
( 1) / 2( | , )
/ 2
l l l l
r s r r
l l l l l
r s rrs rr
n n n n
P e e b
e e
− −
+ + +
<
   +=      ∏ ∏
with 
n
m
 
    the number of combinations of m elements with repe-
titions from a set of n elements. For the prior distribution of the 
hierarchical partitions, we employ
                                    
1
({ }) ( )
L
l l
l
P b P b
=
=∏
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using the equation for P(b) from above with the block and 
node counts for the respective level l and the boundary condition 
B0 = N. The hierarchical model without degree correction 
is obtained by replacing P(A|k, e1, b1) · P(k|e1, b1) by P(A|e1, b1).
Here, we examine four SBM versions: the classical SBM, the 
degree-corrected SBM, the hierarchical SBM and the degree- 
corrected & hierarchical SBM. For fitting the SBM to one of 
these four SBMs (i.e. in order to determine the most probable 
(hierarchical) partition given the data), we converted the adja-
cency matrices of the reduced networks to edge lists in csv format, 
added the disconnected nodes and fed the resulting networks 
as graphs into the Python graph-tool36 framework. Initializing 
a partition according to the prior distribution of the partitions 
from above and using an agglomerative multi-level Markov Chain 
Monte Carlo algorithm37, that module allows for determin-
ing a (potentially hierarchical) partition, b, of the network, G, 
which minimizes the description length, DL, of the SBM33:
2 2
2
2 2
log ( | ) log ( )
log ( ( | ) ( ))
log ( ( | ) ( )) log ( ( | ) ( )).
DL P G b P b
P G b P b
P G b P b P b G P G
=− λ, − λ,
=− λ, ⋅ λ,
=− ⋅ =− ⋅
Thereby, λ captures all parameters of the model apart from 
the partition, such as the number of edges between blocks and 
degree distribution parameters for the degree-corrected SBM, 
in their planar or hierarchical version. Note that the above 
relationship holds only under a microcanonical formulation of 
the priors, i.e. hard constraints imposed on the values of the 
model parameters λ by the structure of the network G the SBM 
is fitted to (see 33, 34), which enables considering only one value 
for the parameter λ for a given partition b and thus
( | ) ( | ) ( ).P P G b PG b = λ, ⋅ λ
Because the probability of the network itself, P(G), is 
constant for a fixed observed network, the description length is 
monotonously inversely related to the probability that partition 
b is responsible for the observed network G, P(b|G). Therefore, 
finding the partition which minimizes the description length 
is equivalent to finding the partition with maximal posterior 
probability, P(b|G). Furthermore, as can be seen in its second 
term in the first line, the description length DL contains a 
“penalty” term for the complexity of the SBM description. Thus, 
it can be used to distinguish which of the four examined SBM 
types (classical, hierarchical, degree-corrected, hierarchical+ 
degree-corrected) is most suitable to describe the network G. 
Due to the large sizes of the networks, sampling over the pos-
terior distribution is costly. Therefore, we decided to compare 
different SBM versions using only the estimated maximum 
of the posterior, i.e. at the partition b with the lowest minimal 
description length, in the expression of the posterior odds 
ratio33. Assuming that both SBM types that are compared, SBM1 
and SBM2, are equally probable a priori, P(SBM1) = P(SBM2), we 
obtain for the posterior odds ratio Λ33:
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We can consider the SBM type with the lowest minimal descrip-
tion length most likely; the distance of the posterior odds 
ratio to 1 determines how much more likely it is than the 
other SBM type. 
We performed 500 runs with random initial partitions for 
each of the four SBM types and each of the six networks. The 
SBM type with lowest minimal description length was used 
for further analyses.
Overrepresentation analysis
Within the mRNA and protein networks, biological annota-
tion of the blocks and overrepresentation was performed using 
Reactome pathways and the package ReactomePA38. We restricted 
our analysis to Reactome pathways containing at least 10 and at 
most 500 annotated genes, all entities of the network were used 
as background. We employed Benjamini-Hochberg multiple- 
testing correction. Pathways were considered overrepresented for 
default settings (p-value < 0.05, q-value < 0.2), and only human 
pathways occurring in the file from the Reactome database, 
https://reactome.org/download/current/ReactomePathwaysRela-
tion.txt (downloaded June 6, 2018, 39), were used. This file was 
also employed as representation of the Reactome hierarchy to 
determine distances between Reactome pathways.
For the metabolite dataset, we mapped the pubchem IDs and 
metabolite names to KEGG compound IDs using the MBRole 
webserver version 240 and merged them semi-manually, 
thereby preferring metabolite names (in case of mismatch with 
pubchem record) and KEGG IDs with pathway annotation. We 
downloaded the human KEGG pathway annotation for the 
mapped metabolites from MBRole and used it as user-defined 
annotation for overrepresentation analysis with the enricher 
function from the package clusterProfiler41. We only consid-
ered pathways with a minimal size of 2 and otherwise the same 
settings as for mRNA and protein overrepresentation analysis.
Comparison to breast cancer signatures and summarizing 
biological function
For comparison to known biological functions relevant to breast 
cancer, we downloaded those gene sets from the MSigDB 
database v6.242, gene set collection C6, oncogenic signatures, 
that arose for the search terms “breast AND (cancer OR car-
cinoma)” on the MSigDB web interface (17 gene sets in total, 
search and download on July 31, 2019). We computed the Reac-
tome pathways that are overrepresented in any of these gene 
sets (as described in section “Overrepresentation analysis”). The 
resulting 43 Reactome pathways were assorted according to 
their Reactome parent pathways (top level Reactome pathways) 
and, for each single pathway, its occurrence among pathways 
overrepresented in SBM-predicted blocks was counted.
For summarizing biological function, we mapped each 
overrepresented Reactome pathway to its parent Reactome pathway 
(top-level pathway). For each network and each hierarchy level, 
we counted the number of occurrence of each Reactome parent 
pathway among the Reactome pathways overrepresented in any 
of the SBM-derived blocks. We normalized these counts to the 
total number of overrepresented pathways in the blocks of the 
network and hierarchy level in order to obtain the percentage of 
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each Reactome parent pathway. Note that we counted the same 
pathway multiple times if it was overrepresented in multiple 
SBM-derived blocks. In order to account for the different 
sizes of the Reactome parent pathways, we further divided the 
percentage of a Reactome parent pathway for a network and 
hierarchy level as described above by the percentage of all 
Reactome pathways that are associated to the Reactome par-
ent pathway. This latter percentage is for example high for 
“metabolism” and “signal transduction” and low for “chromatin 
organization” and “circadian clock”.
Distance measures of Reactome terms and within 
hierarchical SBMs
We employed two distance measures of Reactome pathways 
considering the graph given by the Reactome familial hierarchy 
tree: (i) the distance in terms of number of steps necessary in the 
Reactome hierarchy graph to reach from one pathway to the 
other (distance 1), and (ii) the hierarchy level of the lowest 
common ancestor, or least common subsumer, for ontology 
graphs (distance 2). We incorporated an artificial top-Reactome 
pathway into the hierarchy to connect all pathways with each 
other and to have our distance measures well-defined. It lies at 
the 10th hierarchy level, so the largest distance between two 
pathways is 10 for distance 1 and 18 for distance 2 (nine steps to 
the highest level and nine back). For all comparisons, only blocks 
with at least one overrepresented pathway were considered. 
For comparing the distances of Reactome pathway annotations 
between blocks, i.e. to associate a distance to a pair of blocks, 
we median-averaged the distances over all combinations of 
Reactome pathways associated to the two blocks. For distances 
of pathway annotations within blocks, we median-averaged the 
distances between all possible combination of different Reac-
tome pathways associated to the block. The trivial distances of 
zero for the distance of a Reactome pathway to itself were 
omitted, as well as blocks with only one overrepresented Reac-
tome pathway for intra-block distances. Distances between blocks 
in the SBM hierarchy, as employed in Figure 3D, were defined 
analogously to the distance measure (i) based on the graph of the 
SBM hierarchy.
WGCNA clustering
Alternative clustering using the WGCNA package3 was performed 
following the WGCNA tutorial on clustering. We employed 
the full correlation matrices including self-edges. First, the 
correlation values were scaled to values between zero and 1 (by 
(1+corr)/2), and the soft threshold delivering scale free 
network topology was determined using the pickSoftThreshold. 
fromSimilarity function with default settings. Power estimates 
were 8, 16 and 12 for the mRNA, protein and metabolite 
network, respectively. We calculated the dissimilarity using 
TomSimilarity on the soft thresholded correlation matrix, used 
hclust with method “average” and cutreeDynamic with “deep-
Split” parameter of 4 (mRNA) or 2 (else), “pamRespectsDen-
dro” set to FALSE and “minClusterSize” of 3 (for mRNA, 
metabolite) or 4 (for proteins) to make the clustering most 
similar to the one obtained from the SBM.
Edge prediction
We aim to derive edge confidence scores for each single edge 
in the network exploiting the representation of the network as 
SBM. Let us consider a fixed network given as graph G. If δG 
is a set of edges which do or do not occur in the network G, the 
probability that these edges belong to the observed network 
(for edges missing in G) or do not belong to the observed network 
(for edges from G), P(δG, G), can be written as27:
( )( ) ( )( )b
P G G|b
P G|G P b|G
P G|b
+δδ ∝∑
for b being partitions of the network G (please refer to Fit to 
SBM for further information on notation). The derivation assumes 
that the original network, G and the altered network with edges 
in δG added or removed, G + δG, has been generated by some 
SBM type (and all probabilities are conditional on that SBM 
type), and that the set δG has been chosen by some uniform 
distribution among all possible edges. The proportionality factor 
between the expressions depends on the network G and the 
number of edges in δG, and thus can be in particular neglected 
if only comparing edge confidences between single edges of 
a network. Because we aim to score all edges, and due to the 
sizes of the networks making computations slow, we refrained 
from sampling over the posterior distribution of the partitions 
and instead employed the single-point approximation for edge 
prediction proposed in 27:
( ) ( )( ) ( ) ( ).( ) ( )
*
*
*
b
P G G|b P G G|b
P G|G P b|G P b |G
P G|b P G|b
+δ +δδ ∝ ≈∑
It resorts to neglecting the summands for all partitions except for 
the one, b*, which contributes most to the posterior distribution, 
b* = maxbP(b|G). In addition, the approximation relies on the 
assumption that the estimated optimal partition for the repre-
sentation of G by the SBM is the same for G and its altered 
version with added or removed edge, G + δG, which is reason-
able for our application case of single edge predictions, i.e. for 
δG being composed of a single putatively missing or spurious 
edge. The term P(b*|G) can be considered constant for a 
fixed G and SBM type, so we can shift it to the proportionality 
factor. Considering the microcanonical formulation of the SBM 
(see Fit to SBM), it becomes clear that the edge predictions 
for δG directly depend on the difference between the descrip-
tion length of the original network G with partition b*, DLG,b*, 
and the description length of the altered network G + δG with 
partition b*, DLG+δG,b*27:
( )( ) ( ) 2( ) 2 .( ) ( ) ( ) 2
G G,b*
G,b* G G,b*
G,b*
DL
DL DL
DL
* * *
* * *
PP G G|b P G G|b b
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P G| P G| Pb b b
+δ
+δ−
−
−
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The difference between the description lengths, DLG,b* − DLG+δG,b*, 
was computed via the function get_edges_prob from 
graph-tool36. Note that as of time of writing, get_edges_prob 
does not work for weighted SBMs with real-normal edge 
covariate (see filed issue #452 at graph-tool.skewed.de). In 
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addition, this function employs the natural (instead of the dual) 
logarithm and consequently, the obtained value has to be scaled 
by log2(e) to obtain the plain difference of description lengths.
In order to make clear that neither these edge predictions nor their 
dual (or natural) logarithm correspond to actual probabilities, 
we used the term edge confidence scores or simply edge scores 
throughout the manuscript.
Results
Data preparation, network generation, and reduction
We showcase the SBM-based analysis for data from a subgroup 
of breast cancer patients: those with estrogen receptor negative 
(ER-) tumours. ER status is predictive of patient outcome, with 
ER- leading to unfavourable prognoses, and its assessment is 
part of standard breast cancer patient screening43–45. We used 
three types of molecules reflecting different characteristics of 
tumorous tissue or cells: mRNAs, proteins or metabolites. These 
are key cellular molecules that are widely applied, in isolation 
or in combinations, in different biomedical research domains. 
Their abundance and interconnectedness in networks are 
therefore of high interest if aiming to characterize cells or 
tumorous tissue.
Other potential data types could be e.g. mutations, copy number 
variation, DNA methylation or miRNAs, which are interesting 
avenues to further explore. While they could be useful, there 
are some caveats associated with them, e.g.: the derived interac-
tions within layers are even less directly interpretable than for 
mRNA, protein or metabolite; networks generated from 
mutations and copy number variation are extremely sparse; the 
functional interpretation of DNA methylation data relies on 
mRNA expression and the resulting networks are extremely 
big; the roles of miRNAs are less well known. Therefore, we 
decided to restrict our analyses to the three biomolecular 
entities mRNA, proteins and metabolites.
The Cancer Genome Atlas (TCGA) initiative has provided data 
on the mRNA level (from RNAseq) for 237 ER- breast cancer 
patient tissue samples; mass-spectrometry-based proteomic data 
(4plex iTRAQ) are available for a subgroup of 36 patients29. 
Metabolomics data have been measured by GC-TOF-MS in 
a different breast cancer cohort study for 67 samples30. We 
treated each measured entity as node and established a corre-
lation-based, weighted, biomolecular network for each single 
measurement layer. Therein, each pair of nodes is connected 
by an edge for which the weight is determined by Spearman’s 
correlation of the measurements of the nodes (over the samples), 
delivering values between -1 and 1. Thus, an edge that con-
nects nodes with a correlation close to 1 or close to -1 represents 
strong positive regulation and strong negative regulation, 
respectively; edges connecting nodes with a correlation close 
to zero represent weak or absent regulation. We employed 
Spearman’s correlation because it captures also non-linear rela-
tionships between measurements, and it is robust to outliers 
and any monotonous transformation (e.g. logarithmization). 
We dealt with missing values in the data by replacing them by 
small values (only for NAs due to log transformation of zero 
counts in the mRNA data) or removing entities with >20% 
missing values for all samples (for the protein data). Subse-
quently, we computed the correlation only considering pairwise 
complete observations. The distributions of the computed 
correlation values for the three data types are shown in Figure 1B.
The resulting biomolecular networks capture the relation-
ships of the intracellular machinery, and their analyses deliver 
important insights on altered regulations in disease states2,3. 
However, because these networks are fully connected, i.e., every 
entity is connected to each other entity within a layer, the 
networks become very large and their analyses difficult. A com-
mon approach is to reduce the networks, either by selecting a 
subset of entities as nodes prior to network establishment, mainly 
by using criteria on abundance, or by using the assumption 
that weak regulations are less important for the biological 
network and can be omitted without impairing the represented 
function of the network. We decided on the latter approach in 
order not to bias our choice of considered molecular entities 
and because we wanted to focus on the connections between 
species, i.e. the covariation of expression. Thereby, also lowly 
abundant species can exhibit strong connections, and indeed 
they are found to play a role, as indicated by a non-zero degree, in 
our reduced networks (see Figure S1D46).
We used two different techniques of network reduction by 
thresholding: In the first, we only kept edges for which the 
correlation was significantly different from zero (“sign. corr.”), 
i.e., the regulation being sufficiently strong. Therefore, we com-
puted the p-value associated to each correlation value in the 
networks. Then, for each of the three networks, we applied both 
Bonferroni and Benjamini-Hochberg multiple testing correc-
tion methods along with the classical significance thresholds 
0.01 and 0.05 (see Figure 1C). We finally chose the correction 
method and significance threshold for each data layer consid-
ering a trade-off between minimal network size (i.e. minimal 
computation time for the subsequent fit to SBM) and maximal 
connectedness of the reduced network: We used the combina-
tion of multiple testing correction and significance threshold that 
provided a high degree of reduction while maintaining a 
high percentage of nodes within the largest connected compo-
nent of the network. While the stringent Bonferroni correction 
was necessary to achieve a sufficient degree of reduction for the 
mRNA network, it severely disrupted the connectedness for 
the protein and metabolite data layer leading to less than 30% 
or 65% of the nodes being in the largest connected component 
for protein or metabolite, respectively (see Figure 1C, employed 
thresholds marked in blue). 
In the second reduction method, we systematically removed 
links weaker than increasingly stringent correlation thresholds 
until the reduced network met a criterion of scale-freeness 
(using a function from the WGCNA R package3), see Figure 1D. 
Scale-freeness is considered a key property of self-organized 
networks and thus also of biological molecular networks1. In 
scale-free network formation, highly connected nodes tend to 
attract more connections than lowly connected nodes leading to a 
degree distribution following a power-law with a negative 
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exponent. The least stringent correlation threshold for which 
a sufficiently good fit (scale-free fit index R2 > 0.85, 3) between 
the degree distribution of the reduced network and a power-law 
degree distribution with negative exponent was obtained was 
used for network reduction (networks named “scale-free”). The 
degree distributions of all six reduced networks are shown in 
Figure 1E. The relationship between the two reduction by thresh-
olding approaches are further illustrated in Figure S1A-C46. 
Both reduction techniques are hard-thresholding techniques 
meaning that edges are removed from the networks. The result-
ing six reduced networks, two for each data layer, were used in a 
binary form, i.e., weight information was discarded after reduc-
tion. Some characteristics of the original and reduced networks 
are shown in Table 1. In the following sections, we describe 
how to analyze these different homogeneous cancer networks 
by fitting them to SBMs.
Fitting the reduced networks to stochastic block models
Biological networks are known to be modular and hierarchical. 
Different molecular entities, such as genes, mRNAs, and 
proteins, are interconnected and form different modules to ful-
fill a specific function. Modularity can convey more robustness 
to the overall system, e.g. by preventing perturbations in single 
modules to spread fast and to cause erroneous behavior in other 
modules and thus functions. Hierarchies capture two charac-
teristics of biological systems: (i) the ordered combination of 
functions, i.e., multiple simple functions resulting in more 
complex behavior or responses; and (ii) the inherent levels of 
complex organization of life, from single molecules to cell 
organelles, cells, tissue, organs and whole organisms.
The stochastic block model (SBM) is the simplest form of a 
generative network model based on communities, i.e., group 
structures of the nodes. Thereby, nodes are assigned to blocks 
according to their connectivity properties (Figure 2A left); 
the block associations of two nodes fully determine the prob-
ability of an edge between them. A shortcoming of the classical 
SBM for representations of real networks is that nodes within 
one block need to have similar degrees. The degree-corrected 
version of the SBM35 accounts for that and enables differ-
ent degrees for nodes within a block. Another extension of the 
SBM is its hierarchical version, in which the blocks are further 
partitioned into blocks of higher levels25 (Figure 2A right). This 
model is especially suitable to represent large networks with 
many nodes as it counteracts underfitting. Fitting biological 
networks to hierarchical (also called nested) SBMs is therefore 
most appropriate.
We assessed which of the four following types of stochastic 
block models could best represent the biological networks: the 
classical SBM, the degree-corrected SBM, the hierarchical 
SBM or the degree-corrected and hierarchical SBM (Figure 2B). 
We used the Python module graph-tool36 to fit SBMs to the 
networks, i.e., to find which partition (basal and/or hierarchically 
ordered) describes the network best as SBM.
Note that we also examined the performance of weighted sto-
chastic block models for our purpose of edge prediction as they 
have been successfully employed before for non-biomolecular 
networks18,27,47. However, the characteristics of the optimal 
weighted SBM (number of blocks) were severely impacted 
Table 1. Characteristics of the networks derived from the three data layers. 
Note that genes/proteins/metabolites were removed if having >20% NA values 
(which was the case only for proteins), all other entities were kept as nodes in the 
reduced network even if their degree was zero (i.e. having no edge) after network 
reduction.
Characteristic mRNA protein metabolite
samples 237 36 67
entities (nodes, before NA removal) 18321 10625 162
edges (before reduction) 167820360 56440000 13041
reduced network: scale-free 
minimal correlation 0.603 0.788 0.375
entities (nodes) 18321 8430 162
edges 287790 85980 1825
entities of degree zero 8183 4967 4
entities in largest connected component 9111 3187 158
reduced network: sign. corr. 
minimal correlation 0.395 0.534 0.310
entities (nodes) 18321 8430 162
edges 4260267 2434159 2811
entities of degree zero 1061 3 1
entities in largest connected component 17190 8427 161
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Figure 2. Stochastic block models for representing correlation-based biomolecular networks. (A) In a stochastic block model (SBM) 
representation, the nodes of a network are partitioned into blocks according to their similarity in connectivity. The hierarchical version of the 
SBM (right) imposes in addition hierarchical partitions onto the blocks. (B) Six biomolecular networks derived from transcriptomic, proteomic 
or metabolomics data of breast tumours were fitted to four different types of SBM: the classical SBM (SBM, light blue), the degree-corrected 
SBM (dcSBM, light green), the hierarchical SBM (hSBM, dark blue) and the degree-corrected hierarchical SBM (dchSBM, dark green). 
We performed fits for 500 initial partitions for each network. A fit consists of altering the partitions underlying the SBM such as to minimize 
the description length. The smaller the description length the better the fit. Hierarchical SBMs outperform non-hierarchical SBMs, degree 
correction is required for the mRNA and protein networks. (C) Graphical representations of the best fitting hierarchical stochastic block models 
with degree correction (dchSBM) or without (hSBM) for the networks reduced by significance of correlation (mRNAs, metabolites) or by scale-
freeness (protein). The lowest layer (genes, proteins) is truncated in the mRNA and protein networks, colored lines denote edges between 
blocks of the first level (for mRNA, protein network) or between metabolites (level 0, metabolite network). Edges of blocks or metabolites which 
belong to the same block in the level above have the same colour. The higher-order hierarchical structure is shown in black. 
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Figure  3.  Modules  derived  from  hierarchical  SBM  represent  biological  function.  (A) Percentage of blocks with at least one 
overrepresented Reactome (KEGG) pathway for the best fitting SBM (see Figure 2B) for the mRNA and protein (metabolite) networks, reduced 
by condition on scale-freeness (scale-free) or on significance of correlation (sign. corr.), for each hierarchical level (bars). Black crosses 
denote the percentages of blocks with at least one overrepresented Reactome (KEGG) pathway for three SBMs each with exactly the same 
structures but randomly shuffled mRNAs or proteins (metabolites). (B) For the lowest hierarchy level clustering (level 1) of each of the four 
mRNA and protein SBMs, we calculated the average distances between every pair of Reactome pathways between blocks and those within 
blocks, for a distance measures (i) based on the Reactome hierarchy (see Figure S346 for the results using the alternative distance measure 
(ii)). The lower the distances the more similar are the pathways. The pathways associated to one single block (within) are significantly more 
similar than those associated to different blocks (Welch’s t-test p-value < 0.01) suggesting that biological functions are consistent within 
blocks and distinct between blocks. (C) Distance of Reactome pathways (as in B) between blocks (or within blocks, for distance of blocks 
in SBM being zero) versus the distance of the blocks in the SBM hierarchy for blocks on level 1. We do not find evidence that the Reactome 
hierarchy is reflected in the SBM hierarchy. (D) Between-module vs. within-module distances of Reactome terms as in (B) for blocks of SBM 
hierarchy levels 2-6. (E) Percentage of modules detected by the WGCNA approach with at least one overrepresented Reactome or KEGG 
pathway. Black crosses denote the results for three similar clusterings with randomly shuffled mRNAs, proteins, or metabolites. (F) Between-
module vs. within module distances of Reactome terms as in (B) for the clusterings predicted from WGCNA-based module detection.
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by prior assumptions on the edge weight distributions, and 
the derived edge confidence scores did not coincide well with 
evidence on edge relevance given by the correlations of the 
edges for fully-connected weighted networks (see Figure S246). 
Taking in addition the increased computational effort for fitting 
the weighted SBM compared to the binary version into account, 
we restricted our further analyses to non-weighted SBMs.
The model fit is performed following the rationale of Occam’s 
razor: The simplest model describing the data is the best. Thus, 
we searched for the partition that minimized the description 
length, i.e., the amount of information necessary to describe 
the network as an SBM. Additional information required to 
capture degree-correction and/or hierarchies compared to the 
classical SBM is thereby taken into account. Consequently, it 
can be directly concluded which of the four SBM model types 
is most appropriate for a certain network: The one with the 
lowest minimal description length. The optimization of the 
description length runs via an agglomerative Markov Chain 
Monte Carlo algorithm37. It is non-deterministic and multiple 
initiations of the underlying partition of the SBM are required 
to obtain globally instead of locally optimal partitions. We 
performed optimizations for 500 initial partitions for each 
network and SBM type.
For all four mRNA and protein networks, the classical SBM 
delivered the worst fit and the degree-corrected, hierarchical SBM 
fitted best (Figure 2B left and middle). Degree correction did not 
prove necessary to describe the metabolite networks, for which 
the hierarchical SBMs fitted slightly better than the classical 
SBM (Figure 2B right). A graphical representation of the best 
fitting SBMs in circular layout, showing the blocks from the 
lowest layer (for mRNA, protein) or the metabolites (metabo-
lite network) and their connections in color, and the hierarchical 
structure on top in black, is given in Figure 2C.
SBM-derived communities of the biomolecular networks 
capture and predict biological function
We wanted to assess how well the biological content of the 
biomolecular networks is captured in the stochastic block 
models, i.e., if the clustering of the nodes into the blocks is 
biologically meaningful. To that purpose, we estimated 
whether the blocks show common biological function based on 
Reactome or KEGG pathways. Reactome provides a hierarchi-
cal annotation which enables a definition of a distance between 
terms and a comparison to the hierarchical structure given by 
the SBM, KEGG is one of the annotation databases used most 
for metabolites. In particular, we performed overrepresentation 
analyses of Reactome pathways for the blocks at each level 
of the SBMs of the four protein and mRNA networks, and 
overrepresentation of KEGG pathways for the blocks predicted 
for the two metabolite networks.
We find that a high percentage of blocks in each level has 
at least one associated Reactome or KEGG pathway, i.e., the 
genes of the pathway are overrepresented within the block, they 
occur more frequently than expected by chance (Figure 3A 
bars). Except for the highest hierarchy levels that consist only 
of a few blocks, this percentage is decisively higher than for 
a random clustering of exactly the same structure (results for 
3 random clusterings shown as black crosses in Figure 3A).
Many blocks, however, have not only one but multiple Reac-
tome pathways assigned. If blocks are biologically meaningful, 
we would expect to observe similar Reactome pathways within 
blocks but less similar pathways when comparing the pathways of 
different blocks.
The dissimilarity of Reactome pathways is naturally represented 
by their distance in the Reactome familial hierarchy struc-
ture; the more distant pathways are, the less connected are their 
biological functions. We used two closely related measures to 
assess it: (i) the distance of two pathways is the length of the 
shortest path in the hierarchy tree from one pathway to the other, 
and (ii) the higher the hierarchy level of the lowest common 
ancestor (least common subsumer) of two pathways, the more 
distant they are. Please note that we restricted this analysis 
to the mRNA and protein networks because the KEGG path-
ways employed for metabolite data are only assorted into a very 
shallow hierarchy.
We compared the distances of Reactome pathways using the 
average of the distance measure over pairs of Reactome path-
ways associated with one block (within blocks) and over 
pairs of Reactome pathways associated with two different 
blocks (between blocks) for the lowest hierarchy level blocks 
(level 1, see Figure 3B for distance measure (i), Figure S346 
for distance measure (ii)). Thereby, for all four networks and 
both measures, we observe significantly smaller distances of 
Reactome pathways within blocks than between blocks (Welch’s 
test p < 0.01). This suggests that biological function is coherent 
within and distinct between blocks, thus further enhancing the 
notion that SBMs represent well the biological function of the 
networks. 
In addition, we compared Reactome pathway distances 
between blocks and within blocks for the blocks of the higher 
levels (levels 2-6, Figure 3D). Please note that this analysis could 
only be performed for the subset of SBM hierarchy levels 
with at least three blocks with more than one overrepresented 
Reactome pathway (otherwise, a Welch’s test cannot be 
performed due to low sample count). For higher levels, within- 
block distances are only in some cases significantly lower than 
between-block distances, no general effect can be observed.
Furthermore, we examined the relationship between the 
hierarchies within the SBMs and the hierarchy of the Reac-
tome pathways. First, we defined the distance of blocks within 
a hierarchical SBM by counting the number of steps necessary 
to reach a block from the other (via their lowest common higher- 
level block). Second, we compared the distance within the SBM 
hierarchy of each pair of blocks (on level 1) to the distance 
of their associated Reactome pathways within the Reactome 
hierarchy (Figure 3C, Figure S3B). Thereby, we found only 
a weak positive correlation for Reactome pathway distance 
measure (i), that is even further reduced if neglecting intra-
block coherence, i.e., neglecting blocks with distance zero in 
the SBM hierarchy. From both analyses (Figure 3C–D), we 
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concluded that the hierarchy within the SBM does not strongly 
coincide with the hierarchy within the Reactome pathways.
In order to assess how the clustering by SBM relates to 
established clustering techniques in correlation-based networks, 
we also performed module detection by using the WGCNA 
package3. Note that for this approach, no model reduction is 
necessary, which means that we obtain only one result for each 
data layer. After soft thresholding to enforce scale-free network 
architecture, we employed WGCNA module detection to obtain 
comparable numbers of modules as for the SBM-based approach: 
333 (mRNA), 109 (protein) and 12 (metabolite) for WGCNA; 
these numbers are similar to the 438, 113 and 15 blocks detected 
by SBM for the corresponding scale free networks. Overall, the 
WGCNA clusterings show a larger diversity of module sizes than 
those obtained for the SBM approach (Figure S3D46). For all three 
data layers, a higher percentage of WGCNA-derived modules 
have a biological annotation compared to the blocks from the SBM 
(compare Figure 3E to 3A). However, for the mRNA layer, many 
of the blocks also have an overrepresented pathway annotation 
for randomly shuffled gene names which hints on reduced 
significance of the WGCNA results and better performance 
for the modules detected by fitting to SBM. For protein and 
metabolites, in terms of detection of biologically annotated 
modules, the WGCNA approach seems to provide slightly better 
results than the SBM approach. Comparison of within-module 
distances and between-module distances of the annotated 
Reactome terms for the mRNA and protein networks deliv-
ers significantly lower within-module distances as for the SBM 
clusterings (Figure 3F).
The observed differences derived from WGCNA vs. 
SBM could stem from conceptual differences in the 
approaches: Instead of detecting clusters of entities with 
highly positively correlated abundances only as in WGCNA, 
nodes from the same block are characterized by common con-
nectivity characteristics in the SBM. Clearly, as proteins inter-
act and bind directly for complex formation or regulation, and 
metabolites are interconverted into one another, entities which 
act together tend to have similar abundances and thus the 
modularization by WGCNA shows good results. For the detec-
tion of modules for mRNAs whose interaction can be considered 
less direct, assorting entities with similar connectivity patterns 
as in the SBM-derived modules is beneficial. In addition, the 
WGCNA framework, as most other module detection methods, 
cannot aid in assessing edge relevance - which is enabled by the 
fit of the networks to SBMs.
We furthermore compared the results from the overrepre-
sentation analysis of the SBM-derived blocks to known bio-
logical insights from breast cancer. To that purpose, for the 
mRNA and protein networks, we compared the SBM-derived 
biological Reactome terms to those found for oncogenic signa-
tures obtained from the database MSigDB42. The 43 Reactome 
pathways known to be related to breast cancer according to 
MSigDB (see Methods) stem mainly from the categories extracel-
lular matrix (ECM) organization, signal transduction, cell cycle, 
hemostasis, DNA repair, and few others. All but one of these 
pathways were found as overrepresented, partially with high 
frequency, in SBM-derived blocks of one of the mRNA or pro-
tein networks (Figure 4). The exception is “Defensins” that are 
relevant for antimicrobial immune response and therefore the 
immune system. Its occurrence in oncogenic signatures might 
originate from immune cells measured together with tumour 
tissue. Overall, the two protein networks exhibit less over-
represented pathways, but especially the categories ECM 
organization and DNA repair are well represented in both net-
works, and cell cycle in the network reduced by significance 
of correlation (lower 2 panels in Figure 4). Thus, biological 
functions related to breast cancer are well captured in the 
SBM-derived clustering.
For the metabolite networks, we investigated the KEGG path-
ways found as overrepresented in the SBM-derived blocks 
(Table 2). Therein, especially “Biosynthesis of unsaturated fatty 
acids” is very prominent, it is indeed overrepresented in two 
blocks for each network (not shown) and occurs in different vari-
ations in the scale-free network (e.g. further overrepresented 
terms “Fatty acid biosynthesis”, “Linoleic acid metabolism”, 
Table 2). Indeed, fatty acids synthesis has been related to metas-
tasis, therapeutic resistance and relapse in cancer48. The SBM- 
derived predicted importance of valine, leucine and isoleu-
cine metabolism for breast cancer (Table 2) has been suggested 
before, in particular with respect to leucine49. In addition, ABC 
transporters occur as overrepresented in both SBM-derived 
clusterings of the metabolite networks: They have been suggested 
to play a role in chemoresistance50 and therefore point to one 
possible underlying reason of the bad prognosis of ER- breast 
cancer patients.
In order to identify further biological functions that could 
play a role according to SBM-derived network structures in 
mRNA and protein networks, we summarized the overrepresented 
Reactome pathways on the level of the parent Reactome path-
ways (on the top level of the Reactome hierarchy, Figure 5). 
Thereby, we could retrieve the categories known to be of rel-
evance to breast cancer, in particular ECM organization and cell 
cycle, for all four networks. We found additional categories 
that were observed more frequently than they are represented 
in the Reactome hierarchy: “Metabolism of RNA”, “Metabo-
lism of proteins”, and “Chromatin organization” (columns with 
darker color in Figure 5A). Please note that tRNA synthesis has 
occurred as overrepresented KEGG pathway of the SBM-derived 
structures of the metabolite networks (Table 2) - since tRNA is 
subject to RNA metabolism and is required for the translation 
of proteins, it lies at the interface those two relevant metabolism 
categories predicted from mRNA and protein networks and thus 
complements their predictions. Metabolism of proteins relies 
on amino acids and could be also related to the leucine addic-
tion reported for breast cancer49, and it is supported by the SBM- 
derived predictions in the metabolite network on the relevance of 
the metabolism of further amino acids (Table 2). Of note, metab-
olism in general did not occur with a high frequency (relative to 
the size of the category “Metabolism”, see Figure 5B) revealing 
a certain specificity of the predictions obtained by fitting to 
SBM. The highlight on chromatin organization is an interesting 
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Figure  4.  SBM-derived  blocks  of  mRNA  and  protein  networks  exhibit  biological  functions  related  to  breast  cancer  signature. 
Oncogenic signature gene sets related to breast cancer were retrieved from MSigDB42 and mapped to Reactome pathways. The color 
code shows for how many SBM-derived blocks each of these pathways was overrepresented, for the four mRNA and protein networks 
and each hierarchy level. Hierarchy levels without any blocks with overrepresented pathways are omitted.
SBM-derived prediction complementary to the metabolism 
motif and invites further exploration, e.g. by examining related 
blocks and their connectivity structure in relation to other 
blocks in the SBM.
To summarize, biological functions related to breast cancer are 
well captured in the SBM-derived clustering. Networks derived 
from different datalayers enable different perspectives of 
the phenotype that can support each other or provide comple-
mentary predictions. After the assessment of the biological 
content in the SBM-derived clustering, we moved to the sec-
ond deliverable of the fit of the networks to SBMs: finding 
alternative edge relevance based on global network properties.
Assessing edge relevance by SBM-based edge confidence 
scores
The descriptions of the biomolecular networks as SBMs were 
exploited to determine a confidence score for each existing or 
non-existing edge of the network. This score would capture 
how well the existence (or non-existence) of the edge fits to 
the network’s description by the SBM: Erroneously kept or 
removed edges lead to a worse fit of the SBM to the network, 
and removing or reinstalling these edges lead to fit improvement. 
Indeed, under certain assumptions (see Methods), the derived 
edge confidence score is proportional to the actual absolute 
probability that the edge belongs to the network, and thus signi-
fies relative edge relevance. Therefore, the confidence score 
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Table 2. Overrepresented KEGG pathways for the SBM-derived blocks of the metabolite networks 
(reduced by significance of correlation, sign. corr., or by a criterion on scale-freeness, scale-free).
metabolite network: sign. corr.  metabolite network: scale-free
Biosynthesis of unsaturated fatty acids Biosynthesis of unsaturated fatty acids
Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis
ABC transporters ABC transporters
Valine, leucine and isoleucine biosynthesis Valine, leucine and isoleucine biosynthesis
Valine, leucine and isoleucine degradation Valine, leucine and isoleucine degradation
Amino sugar and nucleotide sugar metabolism Starch and sucrose metabolism
Fatty acid biosynthesis
Linoleic acid metabolism
Ubiquinone and other terpenoid-quinone biosynthesis
Biosynthesis of secondary metabolites
Glycine, serine and threonine metabolism
could be used to predict whether an edge is spurious (or 
missing)17,18,27. A high missing edge confidence score suggests 
that the edge in question is missing and should be restored, it 
has a high relevance; a high spurious edge confidence score 
suggests that the edge in question is spurious and should be 
removed from the network, it has a low relevance. The SBM- 
based edge confidence scores rely on global network connectiv-
ity characteristics and complement the correlation-based weights 
of the edges which stem from the local, measured characteristics 
of their nodes.
For the six reduced networks, all edges that existed in the net-
work were considered as “putatively spurious”. Similarly, all 
edges that were not in the network because they had been removed 
from the (fully connected) correlation-based network during 
the reduction procedure were considered as “putatively miss-
ing”. For each putatively missing and spurious edge, we used the 
Python module graph-tool36 to compute its edge confidence score 
(Figure 6). Thereby, we took advantage of the following fact: 
Entities of degree zero, i.e., nodes that have no connection to 
any other node in the network after reduction, are indistinguish-
able to the SBM. Consequently, also all putatively missing edges 
connecting any of these nodes to a specific second node are only 
distinguishable by this second node, and thus carry the same 
missing edge confidence score. This reduces the number of scores 
we need to compute considerably, depending on the degree of 
reduction (see counts of entities of degree zero in Table 1). We 
display the scores for the different types of missing edges in 
different histograms (Figure 6A, B middle and bottom). For 
very big networks with a low degree of reduction (the mRNA 
and protein networks reduced by significance of correlation), it 
is still computationally not feasible to compute the scores for all 
putatively missing edges. We therefore resorted to comput-
ing it for as many putatively missing edges as we have existing 
edges in the network (i.e. approx. 2.4×106 for the protein network, 
4.6×106 for the mRNA network, see Table 1), and chose those 
with highest absolute edge weights (Figure 6B left and middle).
Recall that the edge confidence scores are relative, i.e., they 
serve for comparing relevance between edges only. In addition, 
computation of the scores relies on the assumption that the 
partition of the originally fitted SBM is correct for the net-
work. Different edge confidence scores might be obtained for 
SBMs with different partitions but with similarly good fit to the 
network. We neglect this complication for the sake of computa-
tional efficiency. Still, we have to keep both facts in mind for the 
interpretation and usage of the edge confidence scores. For 
example, an evident threshold for declaring an edge as relevant 
(“missing”) or not relevant (“spurious”) would be to have the 
respective edge confidence score larger than zero, as this indi-
cates an improvement in fit quality if adding or removing the 
edge, respectively. However, we observe an imbalance of our 
computed scores which is inherent to the approach: Because 
having less edges reduces the complexity of the underlying 
network, removing edges preferentially reduces also the amount 
of information required to describe the SBM, i.e., its description 
length turns smaller, its goodness of fit improves. Therefore, the 
edge confidence score distributions of missing edges are shifted 
to the left - the great majority of edges would be predicted as not 
missing for the threshold of zero, they are not relevant and should 
be left out (Figure 6A, B, 2nd line). Conversely, the spurious 
edge confidence score distributions are shifted to the right - the 
great majority of existing edges would be predicted as spurious, 
they are not relevant and should be removed for an edge score 
threshold of zero (Figure 6A, B, top). Both measures point to 
making the networks smaller.
Evaluation of edge confidence scores based on correlation
In order to determine whether the edge confidence scores are 
overall a reasonable assessment of edge relevance, we compared 
the predicted scores to the edge weights of the edges as derived 
directly from Spearman’s correlation of the measurements 
of the nodes. It is important to note that these edge weights 
(correlations) were used exclusively for the reduction of 
the correlation-based networks. The edge correlations were 
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Figure 5. SBM-derived blocks of mRNA and protein networks predict further pathways relevant for breast cancer. (A) We mapped the 
Reactome pathways to their Reactome parent pathways and counted their occurrence as overrepresented pathway in SBM-derived blocks 
of the four mRNA and protein networks and each hierarchy level. Reactome parent pathways are sorted by the number of pathways they 
summarize (see (B)). The color code gives the percentage of occurrence as overrepresented of each parent pathway (counted occurrence 
divided by total number of overrepresented pathways obtained for the SBM-clustering of the hierarchy level and network) relative to the 
percentage of each parent pathway in the Reactome annotation (number of pathways associated to the parent pathway relative to the number 
of total Reactome pathways). These values indicate whether certain parent pathways occur more frequently than suggested by the size of the 
parent pathways cluster in Reactome. The higher the value (i.e. the darker the color), the more relevant the parent pathway is predicted by 
the SBM-derived network structure. (B) Reactome pathway organization (downloaded from the Reactome website Pathway Viewer, 39). The 
parent pathways that are predicted as especially relevant for breast cancer according to (A) are highlighted.
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Figure 6. SBM-derived edge prediction: Missing and spurious edge confidence scores. (A) Histograms of edge confidence scores for 
the best fitting SBM of the three networks reduced by criterion on scale-freeness for all existing, i.e., putatively spurious edges (spurious edge 
score, top), for the putatively missing edges between nodes with degree > 0 (missing edge score, middle), for the putatively missing edges 
connecting a node of degree 0 to a node with a larger degree (missing edge (disc) score, bottom - only one edge for each node with degree 
> 0 is shown). (B) Edge confidence scores as described in (A) for the networks reduced by criterion on significance of correlation. For the 
mRNA and protein network, missing edge scores (middle) were only computed for the edges with largest absolute correlations of the node 
measurements.
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at no point provided to the SBM, neither during the fitting 
to the SBM (except for the weighted version and only for 
Figures S2, S446) nor during the computation of the edge scores. 
Thus, they are close to an independent validation of the edge 
relevance, edges with large correlation being more relevant to 
the system encoded by the network than edges with a correlation 
close to zero.
Indeed, for all six networks and SBMs, we find an overall posi-
tive correlation between the (absolute) edge correlations and the 
missing edge confidence scores: Edges with high correla-
tion are preferentially predicted as missing, i.e., relevant to the 
network, also in terms of edge confidence score (Figure 7). 
Similarly, we find an overall negative correlation between 
(absolute) edge correlations and spurious edge confidence 
scores: Edges with high correlation are preferentially not 
predicted as spurious, i.e., they are predicted as relevant to the 
network, also in terms of edge confidence score. Consequently, the 
comparison to the edge correlation suggests that SBM-derived 
edge confidence scores could be used as additional informa-
tion for assessing the relevance of edges for multiple omics 
correlation-based networks.
Discussion
Using example cases of correlation-based transcriptomic, 
proteomic and metabolomics networks from breast cancer tumour 
samples, here we show that and how stochastic block models 
can be employed for the analysis of biomolecular networks. The 
networks can be best represented by the hierarchical version 
of the stochastic block models. This gives rise to biologically 
meaningful separation of the biomolecules into many function-
ally relevant blocks. Biological functions related to breast cancer 
are well captured in the SBM-derived clusters and the networks 
derived from the different data layers shed light on different 
perspectives of the phenotype that can support each other and 
result in complementary predictions. In addition, the SBM frame-
work enables the computation of edge confidence scores that 
can be used to predict missing or spurious links.
The representation of the networks by SBMs poses a challenge: 
The model fit and the derivation of edge confidence scores can 
be computationally very demanding, especially for networks 
with many edges. This was the case here for the mRNA networks 
and the protein network reduced by significance of correlation. 
Therefore, the approach of network analysis by SBM seems most 
suitable for smaller and/or sparser networks. On the other hand, it 
delivers two opportunities. 
First, modules derived from blocks in SBMs are not only defined 
as clusters of tight relationships, i.e. co-expression clusters, as 
obtained with other clustering approaches3,9,14. In an SBM, nodes 
from the same block are characterized by common connectiv-
ity characteristics, i.e., common interaction profiles with nodes 
from the same and from other blocks. Consequently, compar-
ing SBM-derived modules between conditions naturally points 
towards detecting altered regulations. Indeed, we found our 
SBM-derived blocks to be biologically relevant to our examined 
phenotype, and comparing SBM-derived structures between differ-
ent phenotypes is an intriguing next step.
Second, the derived edge predictions can reproduce the interac-
tion strengths as estimated from measurements. SBM-based edge 
confidences tend to score missing edges higher that have high 
correlation, i.e., that would be considered a strong regulation, 
an important edge. Analogously, existing edges in the network 
with low correlation tend to be predicted as spurious with high 
confidence, i.e., as dispensable. Keep in mind that the correla-
tions corresponding to the edges were not provided at any point 
to the SBM construction. Thus, the SBM approach proves very 
strong in delivering relevant edge predictions. A further biological 
validation of the predicted edge confidence scores, for example 
by comparison to interaction databases, would be an interesting 
next step.
Still, a question remains: How should the edge confidence scores 
be translated into edge predictions to alter the network, i.e. to 
actually remove or re-install edges? There is a natural threshold 
for declaring an edge as missing or spurious, namely if the 
respective confidence score would be larger than zero. How-
ever, due to the minimal description length approach for 
SBM-based edge relevance assessment, the confidence scores 
are shifted towards reducing the networks as much as possible 
(Figure 6), such that this natural threshold for deriving the 
prediction of actual missingness or spuriousness from the con-
fidence scores is not valid. Further examinations on other 
possible thresholds are required. However, for relative compari-
sons of relevance between edges in a network the SBM-based 
scores are suitable.
Additional directions of SBM-based analysis of biomolecular 
networks remain to be explored.
(i) For edge relevance assessment in other network types, it has 
been proposed that edge predictions with SBMs are more reliable 
if resorting to an ensemble of good fits instead of using the 
best fit only27. Due to the sizes of the employed correlation-based 
biomolecular networks, this approach is computationally not of 
practical relevance here, but it would be an interesting point to 
assess in the future.
(ii) We considered the weighted version of the SBM that 
could be an interesting option for the analysis of biomolecular 
networks because it enables representing fully-connected 
weighted networks as SBM without prior reduction. It could 
prove exciting especially for smaller networks, e.g. primary 
metabolites, or in more targeted data analysis approaches. How-
ever, in our case, we found hints that the weighted version of the 
SBM might not be appropriate for the task of edge prediction 
from SBM-based confidence scores for fully-connected networks 
(see Figure S246). For reduced networks, the results for weighted 
SBMs seem more promising (see Figure S446). A final assess-
ment on the usefulness of the weighted version of the SBMs 
is still pending, as long as nothing is known about interaction 
strength distributions between and within modules: The fitted 
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Figure 7. SBM-derived edge prediction: Validation by correlation. Relationship between edge confidence scores and edge correlations 
(Spearman’s correlation of the measurements at their nodes) for putatively spurious (top) or putatively missing edges between nodes of 
degree > 0 (bottom) for the networks reduced by criterion on scale-freeness (A) or significance of correlation (B). Edge confidence scores 
correlate well to edge correlations, with edges with high SBM-predicted confidence in spuriousness - edges predicted as irrelevant - having 
lower correlations, edges with high SBM-predicted confidence in missingness - edges predicted as relevant - having higher correlations. 
Please note that for the protein network reduced by significance of correlation, due to missing values in the dataset, a fixed significance 
threshold leads to different correlation thresholds and thus the correlation value boundary is blurred (B, middle).
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SBM strongly depends on the prior assumptions chosen for 
these distributions. An extensive analysis of different choices 
would be required, which is beyond the scope of this study.
We propose to employ SBM-based modules and edge confidence 
scores as additional pieces of information to make the results 
of follow-up analyses more robust that rely on relationships 
between nodes, i.e., on edges and their strength. Edges and their 
strength play a key role in interpreting biomolecular effects, 
e.g. of mutations or drugs. If a drug “activates a protein”, this 
typically means alteration of the protein’s interaction strengths 
with other proteins or the DNA. The “mutation of a gene” may 
severely alter the binding properties of the corresponding trans-
lated protein to interaction partners. In sum, interactions and their 
strengths are at the heart of biologically relevant alterations 
in biomolecular networks, and characterizing the former is 
required in order to understand the effects of the latter. The SBM 
framework enables assessing the edge relevance or interac-
tion strength on the basis of consistent, global network charac-
teristics, instead of on the basis of correlation of measurements. 
Especially for personalized analyses which generally rely 
on a characterization by only few error-prone measurements 
of each molecule, this will be crucial to derive more reliable 
predictions.
Data availability
Underlying data
In this study, data from TCGA and CPTAC were used. 
Proteomics data stem from 29, metabolomics data stem from 30. 
The metabolomics raw data can only be obtained upon access-
ing the cited article30; processed data (Spearman’s correlations 
and associated p-values) can be found in the gitlab repository 
below.
Code used to perform the analyses together with a detailed 
work-flow documentation: https://gitlab.com/biomodlih/sbm-for- 
correlation-based-networks
Archived code as at time of publication: https://doi.org/10.5281/
zenodo.336306046
License: GNU GPLv3 license.
Extended data
Zenodo: Analysis of correlation-based biomolecular networks 
from different omics data by fitting stochastic block models. 
https://doi.org/10.5281/zenodo.336306046. This project contains 
the following extended data files:
•    Figure S1: The relationship between network reduction by 
significance of correlation or by scale-freeness
•    Figure S2: The weighted SBM seems not appropriate for 
edge prediction from edge confidence scores for fully con-
nected networks
•    Figure S3: Pathway characteristics for alternative distance 
measure, and block size distributions
•    Figure S4: Edge predictions for a reduced weighted network 
with planar or hierarchical weighted SBMs
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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Revised manuscript satisfied most of the previous comments.
Data preprocessing: 
Datasets are well characterize by the number of samples and features, the missing data imputation
of the three datasets is clarified.
 
Network generation and reduction: 
An explanation is included about the use of 10 as a threshold for the number of edges and its
relation with the test-multiple correction rates performed. Furthermore, the scale-free reduction is
better explained.
 
Stochastic block models:
On the one hand, the SBM model definition is more extensive and the underfitting problem is
addressed. On the other hand, although the comment about the number of partitions is correctly
answered, this explanation is not included in the body text.
 
Functional enrichment:
The use of Reactome and KEGG is now justified. The description of Figure 3 has improved and a
new panel was added. Moreover, two new Figures were included dealing with the biological
insights derived from the SBM blocks. Finally, the edge confident scores section is explained in
more detail.
 
New comments about revised manuscript:
 
Figure 3C and 3D both suggest that SBM block hierarchy does not relates with Reactome’s hierarchy. As
mentioned in text, SBM blocks are characterized by common connectivity characteristics which may not
be completely related with traditional classification based on functions. This is the key point of SBM
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 be completely related with traditional classification based on functions. This is the key point of SBM
derived blocks and it is not fully evaluated in terms of biological meaning, i.e, which pathways are more
related to the SBM blocks? Also, a figure with the SBM networks (network topology) as in Figure 2C but
including tags with enriched pathways should be included in order to evaluate the biological information
that could be extracted from the SBM network. In this sense, Figures 4 and 5 are more suitable than
Figure 3 as a “validation” of the capability of SBM-derived communities to capture biological function
related to breast cancer.
The validation step previously proposed: “A good approach could be to select a gene X and see if the rest
of the genes of the pathways, where gene X is annotated, are in the same block of gene X (or in near
blocks in the hierarchy). And repeat this for a high number of genes.” has not been neither performed or
considered in the response. If not suitable or possible, please explain why.
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, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution License
work is properly cited.
 Ana Conesa
Department of Microbiology and Cell Science, Institute of Food and Agricultural Sciences (IFAS),
University of Florida, Gainesville, FL, USA
 Manuel Ugidos
Institute of Biomedicine of Valencia (IBV), CSIC, Valencia, Spain
This manuscript describes the application of stochastic block models (SBMs) as a method to construct
biological networks from different omics data. Starting from correlation-based networks of breast cancer
data, SBM delivers different modules (or blocks) of the network. In order to assess the usefulness of this
approach, the authors evaluate the biological meaning of the modules obtained performing a functional
enrichment analysis for each module of the network. Finally, the authors include the edge confidence
score computation for each edge in the resulting network.
 
This novel application of SBMs with omics data is interesting but its utility is not clearly explained in the
manuscript. First, the title is confusing, since I understood a single network is obtained from different
omics data, i.e. a multiomic integration analysis, however it is not performed. Furthermore, why are these
three datasets used? It seems the authors want to evaluate the SBM-based networks starting from
datasets with different complexity (different number of features/samples), but the reason is not properly
explained.
As for the SBM model definition, because of the microcanonical formulation because of its hard
constraints, network underfitting could be an important issue. Although underfitting is solved using nested
(hierarchical) or degree-corrected SBMs, an explanation of this phenomena and how to deal with it would
be suitable in “Fit to SBM” methodological section.
Regarding the functional enrichment, the choice of the pathway database is not clear. Why is Reactome
chosen for genes annotation and KEGG for metabolites? Taking into account that breast cancer related
biological findings is not the scope of this manuscript, a deeper analysis of biological information revealed
by network blocks is necessary: which pathways are block-specific? Which pathway or pathways are
present in the bigger block?  Do the pathway distances between blocks have any relation with previous
knowledge about breast cancer? Furthermore, the pathway distances within and between blocks are
computed just for the lower level of blocks. Since the network is hierarchical, pathway distances can be
obtained for each level. This would indicate if the hierarchy is biological meaningful too. Moreover, the
same genes are known to be annotated to related pathways. Therefore, this expected result does not
represent a validation to determine the biological meaning of the blocks in the network. A good approach
could be to select a gene X and see if the rest of the genes of the pathways, where gene X is annotated,
are in the same block of gene X (or in near blocks in the hierarchy). And repeat this for a high number of
genes.
Finally, the edge confidence score looks like important to improve the network characterization, however
they do not use this score to optimize the final network. I was expecting the comparison between the
original SBM-based network and the corrected SBM-based network via edge confidence score
optimization. In order to use the edge confidence scores, a way to compute thresholds for missing and
spurious edges should be proposed.
 
Resuming, SBM-based biological networks are a new way to represent omics data and it represents a
novel approach for SBMs. However, a novel application should be coupled with a suitable interpretation
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 novel approach for SBMs. However, a novel application should be coupled with a suitable interpretation
of its results. Moreover, the main conclusion or this manuscript is not clear and the main question for a
new methodological development is unanswered, why should I use this method?
 
Specific points:
1) Data preprocessing:
Why are the three datasets used? Is it just a matter of different complexity? Datasets are not
completely characterized as the number of features is not indicated.
Authors say missing values of metabolite data were imputed previously. It is not clear whether they
performed the imputation or not. In case they did, the algorithm used is not indicated. If missing
values of metabolite data were imputed, why weren't the missing values of protein data?
2) Network generation and reduction:
They use different test-multiple correction rates for mRNA, protein and metabolites in order to
obtain a similar degree of reduction. The authors should demonstrate this does not lead to any
biases. The reduction objective is set at 10  edges, is there any reason?
In Figure 1.D, a linear relationship is expected for the blue dots but it not perfectly linear, why?
Could the scale-free reduction be modified to improve it?
 
3) Stochastic block models:
How are the number of initial partitions (500) defined? Is there any relation between the suitable
number of initial partitions and the network complexity (size)?
 
4) Functional enrichment:
They use Reactome database for genes annotation and KEGG for metabolites, but there is no an
explanation of why that choice.
Figure 3.C is confusing. I do not understand the objective of this analysis. In order to demonstrate
the biological meaning of the hierarchical SBM, the pathway distances comparison within and
between blocks at every hierarchical level (as in Figure 3.B) would be better than the provided
analysis.
As mentioned before, a deeper biological interpretation of the network is necessary.
I am not sure what the clustering analysis is contributing to. Modules obtained by WGCNA shows
good results looking at the number significant of pathways, but are they biologically relevant? Are
they related to breast cancer?
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
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 Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Bioinformatics, functional genomics, transcriptomics
We confirm that we have read this submission and believe that we have an appropriate level of
expertise to state that we do not consider it to be of an acceptable scientific standard, for
reasons outlined above.
Author Response 12 Aug 2019
, Max Delbrück Center for Molecular Medicine in the Helmholtz Association,Katharina Baum
Berlin, Germany
We thank Dr. Ana Conesa and Manuel Ugidos for their time and effort they invested into
commenting our work. They raised important points that we carefully addressed in our revised
version 2 of the manuscript. Please find our specific replies and the description of introduced
changes below. 
>This manuscript describes the application of stochastic block models (SBMs) as a method to
construct biological networks from different omics data. Starting from correlation-based networks
of breast cancer data, SBM delivers different modules (or blocks) of the network. In order to assess
the usefulness of this approach, the authors evaluate the biological meaning of the modules
obtained performing a functional enrichment analysis for each module of the network. Finally, the
authors include the edge confidence score computation for each edge in the resulting network.
>This novel application of SBMs with omics data is interesting but its utility is not clearly explained
in the manuscript. First, the title is confusing, since I understood a single network is obtained from
different omics data, i.e. a multiomic integration analysis, however it is not performed.
>Furthermore, why are these three datasets used? It seems the authors want to evaluate the
SBM-based networks starting from datasets with different complexity (different number of
features/samples), but the reason is not properly explained.
>As for the SBM model definition, because of the microcanonical formulation because of its hard
constraints, network underfitting could be an important issue. Although underfitting is solved using
nested (hierarchical) or degree-corrected SBMs, an explanation of this phenomena and how to
deal with it would be suitable in ‘Fit to SBM’ methodological section.
>Regarding the functional enrichment, the choice of the pathway database is not clear. Why is
Reactome chosen for genes annotation and KEGG for metabolites?
 >Taking into account that breast cancer related biological findings is not the scope of this
manuscript, a deeper analysis of biological information revealed by network blocks is necessary:
which pathways are block-specific? Which pathway or pathways are present in the bigger block?
 Do the pathway distances between blocks have any relation with previous knowledge about
breast cancer?
> Furthermore, the pathway distances within and between blocks are computed just for the lower
level of blocks. Since the network is hierarchical, pathway distances can be obtained for each
level. This would indicate if the hierarchy is biological meaningful too. Moreover, the same genes
are known to be annotated to related pathways. Therefore, this expected result does not represent
a validation to determine the biological meaning of the blocks in the network. A good approach
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 a validation to determine the biological meaning of the blocks in the network. A good approach
could be to select a gene X and see if the rest of the genes of the pathways, where gene X is
annotated, are in the same block of gene X (or in near blocks in the hierarchy). And repeat this for a
high number of genes.
>Finally, the edge confidence score looks like important to improve the network characterization,
however they do not use this score to optimize the final network. I was expecting the comparison
between the original SBM-based network and the corrected SBM-based network via edge
confidence score optimization. In order to use the edge confidence scores, a way to compute
thresholds for missing and spurious edges should be proposed.
> Resuming, SBM-based biological networks are a new way to represent omics data and it
represents a novel approach for SBMs. However, a novel application should be coupled with a
suitable interpretation of its results. Moreover, the main conclusion or this manuscript is not clear
and the main question for a new methodological development is unanswered, why should I use this
method?
 
Response:
We thank the reviewers for the nice summary of our work. In order to sharpen the focus, we
clarified in the abstract and at the end of the introduction that our goal is to pave the ground for the
usage of the SBM model for different types of biomolecular networks. Investigating the capability of
SBMs for representing and analysing different types of biological networks was the key challenge
addressed in our article. We did not intend to compare the networks between layers, but rather
assess to which extent the SBM is applicable to derive useful information in terms of (i) relevant
clustering as well as (ii) network-based, alternative edge scores. 
We have shown that a lot more SBM-predicted blocks have biological counterparts (i.e. more
genes or metabolites associated with certain Reactome or KEGG terms are clustered together)
than expected by chance, and we show in our revised version that biological processes known to
be relevant to the examined phenotype can be derived (new Figs. 4, 5, Table 2). In addition, we
showed that the SBM-based edge relevance scores coincide with the correlation values (which
have not been given to fit the network to the SBM). These results support our hypothesis that the
SBM is suitable to represent and analyze biomolecular networks in which interactions are derived
from correlations. This opens the avenue to new types of analyses using the SBM and its output for
which this work lays the foundation. 
We hope that the reviewers will also find that the revised version supports this reasoning and the
derived conclusion. 
 
In response to other points that were raised only here but not in the specific points include below:
To improve the clarity of the description of the data usage from the beginning, we reformulated the
according sentences in the abstract and introduction which now read: 
‘We apply SBM-based analysis independently to three correlation-based networks of breast
cancer data originating from high-throughput measurements of different molecular layers:
transcriptomics, proteomics, or metabolomics.’
‘Here we showcase the SBM-based analysis (overview in Fig. 1A) for three networks of different
molecular types, derived from either transcriptomic, proteomic or metabolomics data of breast
cancer tumours.’
In order to facilitate the understanding of the different SBM versions, we added an explanation on
the hierarchical and degree-corrected version of the SBM into the methods part and comment on
the relationship between underfitting and the hierarchical SBM in the revised methods section.
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>Specific points:
>1) Data preprocessing:
Why are the three datasets used? Is it just a matter of different complexity? Datasets are not
completely characterized as the number of features is not indicated.
Response:
Protein, mRNA and metabolites are key molecules in cells, which are widely applied, in isolation or
in combinations, in different biomedical research domains. Their abundance and
interconnectedness in networks are therefore of high interest if aiming to characterize cells or
tumorous tissue. We used them to illustrate three examples for cellular interaction networks, whose
interactions have different biological meanings. Moreover, in the revised article now we explain that
we use these networks to reflect different characteristics of tumorous tissue/cells.
The number of features (i.e. number of mRNAs, proteins and metabolites) are given in the network
characteristics in Table 1 (‘entities’ before NA removal and afterwards). In order to improve
accessibility to the reader, we also state these numbers in the methods part of the revised
manuscript and clearly identify them as feature count (‘mRNA, protein, metabolite data for
ER-breast cancer tumors’).
>Authors say missing values of metabolite data were imputed previously. It is not clear whether
they performed the imputation or not. In case they did, the algorithm used is not indicated. If
missing values of metabolite data were imputed, why weren't the missing values of protein data?
Response:
We used the metabolite data as provided in Budczies et al. 2009 in which imputation had been
performed. In order to clarify this, we reformulated the sentence in the methods part to ‘The
metabolite data did not contain missing values as imputation had been performed in the original
publication .’
We used the processed protein data as provided in the original publication (Mertins et al, 2014). In
general, in contrast to missing values in metabolite data which are usually considered to occur due
to abundance below detection limit, missing values in protein data can have multiple different
reasons making imputation less straightforward. Because we do not focus on data pre-processing
here, we kept the data as close as possible to those originally published and rather took the
opportunity to provide an idea of how to incorporate datasets with missing data into our proposed
analysis framework.
 
>2) Network generation and reduction:
They use different test-multiple correction rates for mRNA, protein and metabolites in order to
obtain a similar degree of reduction. The authors should demonstrate this does not lead to any
biases. The reduction objective is set at 10 edges, is there any reason?
Response:
We reformulated and describe this part in more detail in the revised manuscript. In fact, we
intended to provide examples for different corrections methods and thresholds which are
frequently used, and to achieve a high degree of reduction (to reduce runtime for SBM fit) while still
ensuring that the resulting biomolecular network is as connected as possible (see Fig. 1C).
Similarity of the degree of reduction between the three data layers was not a goal to achieve. The
[Budczies et al. 2009]
7
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 Similarity of the degree of reduction between the three data layers was not a goal to achieve. The
border of 10  edges arose out of computation time considerations (runtime scales with edge count
for SBM fit in graph-tool, they correspond to several hours and Gbs of memory consumption for a
single initialization), and thus could be adapted to each user’s case.
 
>In Figure 1.D, a linear relationship is expected for the blue dots but it not perfectly linear, why?
Could the scale-free reduction be modified to improve it?
Response:
Usually, a perfect fit to scale-freeness cannot be achieved because altering the cut-off threshold
leads to removal of multiple edges at the same time; the achievable combinations of which edges
belong to the network are fully determined by the correlation values associated to the edges. We
show possible scale-free fit indices (that index is a measure of how closely the node degree
distribution resembles a power-law, i.e. how close the network is to scale-freeness) of the networks
reduced by edge thresholding in new Fig. 1D. Therein, it also becomes clear that other thresholds
could be used and can lead to ‘better’ scale-freeness in the resulting networks – while at the same
time making the resulting network less connected. Other specific requirements on the degree of
scale-freeness can be adapted on a case-by-case basis.
>3) Stochastic block models:
How are the number of initial partitions (500) defined? Is there any relation between the suitable
number of initial partitions and the network complexity (size)?
Response: 
The number of initializations was chosen as first assessment whether this is sufficient to be able to
distinguish between the different SBM types – which was the case. As is clear, for some networks
different SBM types are more closely related whereas for others, they are well more separated.
This will depend on the actual network/data that is fitted and serves as orientation. Of course, more
initializations are always better, but it is subject to a trade-off between computation time and finding
a good partition.
>4) Functional enrichment:
They use Reactome database for genes annotation and KEGG for metabolites, but there is no an
explanation of why that choice.
Response:
We added the explanation to the revised version. Reactome provides a hierarchical annotation
which qualifies it for comparison to the hierarchical structure given by the SBM, KEGG is one of the
annotation databases used most for metabolites.
>Figure 3.C is confusing. I do not understand the objective of this analysis. In order to demonstrate
the biological meaning of the hierarchical SBM, the pathway distances comparison within and
between blocks at every hierarchical level (as in Figure 3.B) would be better than the provided
analysis.
Response:
We altered the accompanying description of Fig. 3C. What we intended is to relate the distance of
two SBM blocks in the SBM hierarchy (x-axis) to the distances between the Reactome terms
associated to the blocks (y-axis). For a matching hierarchy structure of Reactome and SBM, we
would expect a positive correlation, i.e. more distant SBM blocks in the SBM hierarchy having
7
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 would expect a positive correlation, i.e. more distant SBM blocks in the SBM hierarchy having
more distantly related Reactome terms. We do not find convincing evidence for this. 
To clarify the approach, we restructured Fig. 3 (by moving the results for the second distance
measure into the supplement, new Fig. S3).
In addition, we now also include the analysis of within-block distance vs. between-block distances
for the other hierarchy levels as suggested by the reviewer (new Fig. 3D). As in our previous
analysis in Fig. 3C, we cannot find strong evidence for the hierarchy of the SBM coinciding with the
Reactome hierarchy. Please note that the numbers of blocks with annotation get low in higher
hierarchy levels, thereby reducing the number of hierarchy levels that can be considered for this
analysis.
 
>As mentioned before, a deeper biological interpretation of the network is necessary.
I am not sure what the clustering analysis is contributing to. Modules obtained by WGCNA shows
good results looking at the number significant of pathways, but are they biologically relevant? Are
they related to breast cancer?
Response: 
We provide additional biological interpretations of the clustering results in the revised version of the
manuscript (see new Figs. 4, 5, Table 2). They show that the SBM-derived clustering can detect
biological pathways known to be implicated in breast cancer according to oncogenic signatures
from MSigDB, such as extracellular matrix organization or the cell cycle (see new Fig. 4), or fatty
acid biosynthesis (Table 2). In addition, the relevance of further processes can be predicted, e.g.
 chromatin organization (new Fig. 5).
 No competing interests were disclosed.Competing Interests:
 29 April 2019Reviewer Report
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© 2019 Pineda San Juan S. This is an open access peer review report distributed under the terms of the Creative
, which permits unrestricted use, distribution, and reproduction in any medium, provided theCommons Attribution License
original work is properly cited.
   Silvia Pineda San Juan
 Division of Transplant Surgery, Department of Surgery, University of California, San Francisco (UCSF),
San Francisco, CA, USA
 Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
The manuscript provides an innovative way of using stochastic block models to perform networks for
different omics data.
The idea is interesting but the application should be better characterized. I was expecting a network
integrating the different datasets, but the network is performed separately per each dataset. This fact
should be addressed at the very beginning to avoid confusion to the readers. 
Also, the use of the three datasets is not justified, why these three and no others? 
It looks like the authors want to compare the three networks applied to the three datasets (mRNA,
proteins, and metabolites) but the different sample size among other factors makes them not comparable.
Finally, one of my main concern is that there is not a clear conclusion of the study, are they proposing a
1
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 Finally, one of my main concern is that there is not a clear conclusion of the study, are they proposing a
network that is better than the ones that already exist? (this is not assessed). Are they finding new
biological insights for breast cancer? (this is not shown). The final conclusion is not clear since the
authors did not give a biological example of the method application. It is not clear if the method
outperforms others or if the method is able to find new biological interpretations, etc. Why people should
use this method? What type of information will they obtain?
More specific points: 
Data preparation and network generation:
It is not clear to me why the authors used mRNA, protein and metabolites for this network study. Is
it just because they were available, or is there a hypothesis under this selection? Why don't they
use other omics data available in the TCGA? The sample size is pretty reduced for the proteomics
data with only 36 samples. The other thing I do not understand is why they used metabolomics
data measured in other individuals. And for the mRNA they do not give an exact sample size. 
 
Why do they use Bonferroni for mRNA expression and Benjamini-Hochberg for protein, metabolite
and just 0.01 for protein? This should be better justified.
 
They replace 0 values by NA, why? There is a big difference between a lack of expression and a
missing value.
 
Do they filter for those genes that have a very low expression among samples? They only specify
this for protein data, but what about mRNA expression? Are they considered only 0 for low
expression or a very small cut-off normally used in mRNA analysis?  
 
Regarding the scale-free reduction. They explain that the technique removes weak links until met a
criterion based on WGCNA package, but it does not well explain the process for this and how they
applied this to the data. Please explain. 
Fitting SBM:
They built the network based on a stochastic block model (SBM) representation, the nodes of a
network are partitioned into blocks according to their similarity in connectivity. It is not clear how the
SBM is applied to the data and how the similarities are obtained. 
For the SBM representing biological function:
The whole module is unclear to me since they do not provide any biological or functional
interpretation. I don't understand the goal of this. Figure 3 is also quite confusing.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
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 If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: Statistics, Computational biology, Data analysis, Genomics.
I confirm that I have read this submission and believe that I have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard, however I have significant
reservations, as outlined above.
Author Response 12 Aug 2019
, Max Delbrück Center for Molecular Medicine in the Helmholtz Association,Katharina Baum
Berlin, Germany
We thank Dr. Silvia Pineda San Juan for the careful revision of our manuscript. Her comments
helped us enhancing the clarity and stringency of our presentation and the reader's accessibility to
our work. We respond to her specific comments and describe the introduced changes to version 2
of our manuscript below.
>The manuscript provides an innovative way of using stochastic block models to perform networks
for different omics data.
The idea is interesting but the application should be better characterized. I was expecting a
network integrating the different datasets, but the network is performed separately per each
dataset. This fact should be addressed at the very beginning to avoid confusion to the readers. 
 
Response:
We thank the reviewer for her appreciation of our idea. In order to improve the clarity of the
description of the data usage from the beginning, we reformulated the corresponding sentences in
the abstract and introduction which now read: 
‘We apply SBM-based analysis independently to three correlation-based networks of breast
cancer data originating from high-throughput measurements of different molecular layers: either
transcriptomics, proteomics, or metabolomics.’
‘Here we showcase the SBM-based analysis (overview in Fig. 1A) for three networks of different
molecular types, derived from either transcriptomic, proteomic or metabolomics data of breast
cancer tumours.’ 
 
>Also, the use of the three datasets is not justified, why these three and no others? 
It looks like the authors want to compare the three networks applied to the three datasets (mRNA,
proteins, and metabolites) but the different sample size among other factors makes them not
comparable.
Finally, one of my main concern is that there is not a clear conclusion of the study, are they
proposing a network that is better than the ones that already exist? (this is not assessed). Are they
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 Finally, one of my main concern is that there is not a clear conclusion of the study, are they
proposing a network that is better than the ones that already exist? (this is not assessed). Are they
finding new biological insights for breast cancer? (this is not shown). The final conclusion is not
clear since the authors did not give a biological example of the method application. It is not clear if
the method outperforms others or if the method is able to find new biological interpretations, etc.
Why people should use this method? What type of information will they obtain?
 
Response: 
In order to sharpen the focus, we clarified in the abstract and at the end of the introduction that our
goal is to pave the ground for the usage of the SBM model for different types of biomolecular
networks. Investigating the capability of SBMs for representing and analysing different types of
biological networks was the key challenge addressed in our article. We did not intend to compare
the networks between layers, but rather assess to which extent the SBM is applicable to derive
useful information in terms of (i) relevant clustering as well as (ii) network-based, alternative edge
scores. 
We have shown that a lot more SBM-predicted blocks have biological counterparts (i.e. more
genes or metabolites associated with certain Reactome or KEGG terms are clustered together)
than expected by chance, and biological processes known to be relevant to the examined
phenotype are can be derived (new Fig. 4, 5, Table 2). In addition, we showed that the SBM-based
edge relevance scores coincide with the correlation values (which have not been given to fit the
network to the SBM). These results support our hypothesis that the SBM is suitable to represent
and analyze biomolecular networks in which interactions are derived from correlations. 
This opens the avenue to new types of analyses using the SBM for which this work lays the
foundation. 
To strengthen our findings, as suggested by the reviewer, we now also include more biological
interpretations of the clustering results (see Figs. 4, 5, Table 2). They show that the SBM-derived
clustering can detect biological pathways known to be implicated in breast cancer according to
oncogenic signatures from MSigDB, such as extracellular matrix organization and the cell cycle
(see new Fig. 4), or fatty acid biosynthesis (Table 2). In addition, the relevance of further processes
can be predicted, e.g. the chromatin organization (new Fig. 5).
>More specific points: 
>Data preparation and network generation:  
It is not clear to me why the authors used mRNA, protein and metabolites for this network study. Is
it just because they were available, or is there a hypothesis under this selection? Why don't they
use other omics data available in the TCGA? The sample size is pretty reduced for the proteomics
data with only 36 samples. The other thing I do not understand is why they used metabolomics
data measured in other individuals. And for the mRNA they do not give an exact sample size. 
Response:
Protein, mRNA and metabolites are key molecules in cells, which are widely applied, in isolation or
in combinations, in different biomedical research domains. Their abundance and
interconnectedness in networks are therefore of high interest if aiming to characterize cells or
tumorous tissue. We used them to illustrate three examples for cellular interaction networks, whose
interactions have different biological meanings. Moreover, in the revised article now we explain that
we use these networks to reflect different characteristics of tumorous tissue/cells.
Other potential data types could be e.g. mutations, copy number variation, DNA methylation or
miRNAs, which are interesting avenues to further explore. While they could be useful, there are
some caveats associated with them, e.g.: the derived interactions within layers are even less
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 some caveats associated with them, e.g.: the derived interactions within layers are even less
directly interpretable than for mRNA, protein or metabolite; networks generated from mutations and
copy number variation are extremely sparse; the functional interpretation of DNA methylation data
relies on transcription and the resulting networks are extremely big; the roles of miRNAs are less
well known. Therefore, we decided to restrict our analyses to the three biomolecular entities
mRNA, proteins and metabolites. We included these considerations when introducing the
employed data layers in the results part of the revised manuscript. 
Concerning the metabolite data: We are convinced that metabolites characterize a highly
interesting layer of intra-tumor processes which is complementary to the gene expression
associated layers mRNA and proteins. Unfortunately, metabolomics have not been measured for
TCGA samples which is why we resorted to an alternative cohort for this data layer.
Please note that the number of tumour samples for each data layer were stated in the methods
section (mRNA: 237, protein: 36, metabolite: 68). We now included that value for the mRNA data
layer also into the main text. 
>Why do they use Bonferroni for mRNA expression and Benjamini-Hochberg for protein,
metabolite and just 0.01 for protein? This should be better justified.
Response:
We explain our approach for network reduction more in detail in the methods and results part of the
revised version of the manuscript. In fact, at first, we applied both Bonferroni and
Benjamini-Hochberg correction methods, both of which are widely used and accepted, along with
the classical significance thresholds 0.01 and 0.05 to the networks of all three data layers (see Fig.
1C). We finally chose the correction method and threshold for each data layer considering a
trade-off between minimal network size (i.e. minimal computation time for the subsequent fit to
SBM) and maximal connectedness of the reduced network: We used the combination which
provided a high degree of reduction (less than 10 million edges in the network) while maximizing
the size of the largest connected component in the network. While the stringent Bonferroni
correction is necessary to achieve a sufficient degree of reduction for the mRNA network, it
severely disrupted the connectedness for the protein and metabolite data layer leading to less than
30% or 65% of the nodes being in the largest connected component for protein or metabolite,
respectively (see Fig 1C). 
Using different correction methods and significance thresholds serve as examples of typical
scenarios which could be envisioned during network reduction. Finally, every user could use their
own thresholds reasonable for network reduction.
>They replace 0 values by NA, why? There is a big difference between a lack of expression and a
missing value.
Response:
We replaced NAs by -10 in the log-counts of the RNAseq data. As stated in the methods part, the
reason for this is the following: The RNAseq data are logarithmized (relative) counts. In this case
the NAs are therefore artefacts from logarithmizing a zero count. Our replacement served to
reverse this artefact.
>Do they filter for those genes that have a very low expression among samples? They only specify
this for protein data, but what about mRNA expression? Are they considered only 0 for low
expression or a very small cut-off normally used in mRNA analysis?  
Response:
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 Response:
Apart from the replacement of NAs by very small values (-10 in log-counts) in the mRNA data, we
use the data as provided by TCGA. The rationale for this is to reduce bias with respect to which
nodes we consider. Since we do not focus on expression strength, but on the connection between
molecular species, i.e. co-variation of expression, also lowly abundant species could, and indeed
do, play a role, i.e. they have non-zero degree in the reduced networks. We dedicate new Figure
S1D to an illustration of this fact.
One can imagine multiple other criteria of entity removal prior to analysis (e.g. tissue-specific
GTEx, using pathways of interest) but this is not the focus of our work.
>Regarding the scale-free reduction. They explain that the technique removes weak links until met
a criterion based on WGCNA package, but it does not well explain the process for this and how
they applied this to the data. Please explain. 
Response:
We incorporated a more detailed explanation of this reduction technique in the methods part and
added an additional panel to Fig. 1 (Fig. 1D) which illustrates intermediate results of the process.
This is the revised methods part: ‘For the reduction by imposing a scale-free architecture of the
pickHardThresholdreduced network, we employed the  function of the WGCNA package
(Langfelder et al, 2008) with the default requirement (0.85) on goodness of fit to a power-law
degree distribution of the nodes. Given the symmetric absolute correlation matrix of the network
edges, this function reduces the network by one of a given set of edge thresholds at a time and
determines the scale-free fit index R  which lies between 0 (bad fit) and 1 (perfect fit) by comparing
the resulting degree distribution of the reduced network to a power-law degree distribution. The
lowest of the tested edge thresholds that gives a scale-free fit index > 0.85 is reported as estimated
threshold. For the edge thresholds, we started with a grid with stepsize 0.05 between 0.3 and 0.95,
refining according to the resulting estimates to vectors with stepsize 0.001 between 0.5 and 0.625
for the mRNA network, between 0.7 and 0.82 for the protein network and between 0.3 and 0.4 for
the metabolite network. Finally estimated edge correlation thresholds were 0.603 (mRNA), 0.788
(protein), and 0.375 (metabolite).’
>Fitting SBM:  
They built the network based on a stochastic block model (SBM) representation, the nodes of a
network are partitioned into blocks according to their similarity in connectivity. It is not clear how the
SBM is applied to the data and how the similarities are obtained. 
Response:
We extended the corresponding section describing the SBM in the Methods, in which we now also
summarize the equations underlying the building of the SBM and the relationship between model
likelihood and properties of the network graph derived from the data.
>For the SBM representing biological function:  
The whole module is unclear to me since they do not provide any biological or functional
interpretation. I don't understand the goal of this. Figure 3 is also quite confusing.
Response:
The assumption behind the analysis is that a predicted block structure is meaningful if many of the
predicted blocks have a biological counterpart, e.g., biological pathway. Such an analysis was
performed as a starting point for assessing potential biological relevance. Nevertheless, because
we agree that additional biological interpretations would benefit the reader, we included other
examples of biological interpretations (new Figs. 4, 5, Table 2 and accompanying description in the
2
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 1.  
2.  
3.  
4.  
examples of biological interpretations (new Figs. 4, 5, Table 2 and accompanying description in the
results section). In addition, in order to improve accessibility, we reduced the contents of Fig. 3 (by
only showing results for one distance measure) and clearly indicated which SBM hierarchy level
 the examined blocks stem from. 
 No competing interests were disclosed.Competing Interests:
 26 April 2019Reviewer Report
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© 2019 Xie L et al. This is an open access peer review report distributed under the terms of the Creative Commons
, which permits unrestricted use, distribution, and reproduction in any medium, provided the originalAttribution License
work is properly cited.
 Lei Xie
Department of Computer Science, Hunter College, The City University of New York, New York, NY, USA
 Yue Qiu
City University of New York, New York, NY, USA
The paper by Baum et al describes a method to construct biological networks from omics data using
stochastic block models (SBMs). The application of SBM on mRNA, protein and metabolic data gives a
new way of deriving information from correlation based biological networks. The proposed method could
be a useful addition to network biology. To strengthen the manuscript, I would suggest the following points
to be addressed:
In the over representation analysis, while the statistics on distance of Reactome/KEGG terms
shows the block generated here is significantly better than random. Is it possible to provide a such
comparison between the clustering result by SBM and WGCNA?
In the network reduction step, a linear relationship is expected between log-frequency and
log-node-degree. While the scale-free fit index (R ) will be > 0.85 with WGCNA default
requirement, how different threshold affect that linearity is not clear from Fig 1D. Also, how well can
the network be reduced by significance of correlation fit to a scale free network?
To demonstrate that SBM can provide biological insight, more detailed analysis on the benchmark
data sets could be useful. For example, what are unique and common pathways for different breast
cancer subtypes, how well are these findings consistent with existing knowledge?
Figure 4 shows SBM based confidence score can be used to predict the existence of an edge.
However, it is not clearly stated how the edges are determined as putatively missing or spurious.
Also, the description for figure 4A is hard to understand. 
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Partly
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
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 Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
Reviewer Expertise: bioinformatics, systems biology
We confirm that we have read this submission and believe that we have an appropriate level of
expertise to confirm that it is of an acceptable scientific standard, however we have significant
reservations, as outlined above.
Author Response 12 Aug 2019
, Max Delbrück Center for Molecular Medicine in the Helmholtz Association,Katharina Baum
Berlin, Germany
We thank Prof. Lei Xie and Yue Qiu for their comments that helped improving the accessibility of
the presented contents and strengthened the manuscript. In the following, we answer to the
specific points they raised and how we addressed them in version 2.
 
 
>The paper by Baum et al describes a method to construct biological networks from omics data
using stochastic block models (SBMs). The application of SBM on mRNA, protein and metabolic
data gives a new way of deriving information from correlation based biological networks. The
proposed method could be a useful addition to network biology. To strengthen the manuscript, I
would suggest the following points to be addressed:  
>In the over representation analysis, while the statistics on distance of Reactome/KEGG terms
shows the block generated here is significantly better than random. Is it possible to provide a such
comparison between the clustering result by SBM and WGCNA?
Response: 
 We thank the reviewers for their appreciation of our work. We now also provide the computation of
the SBM distances for the mRNA and protein WGCNA clustering results (see new Fig. 3F and new
Fig. S3C). They show also a bigger distance between clusters than within clusters. We added the
resulting p-values to the comparison of the distances for both SBM (Fig. 3B, D) and WGCNA (Fig.
3F, S3C) approach.
>In the network reduction step, a linear relationship is expected between log-frequency and
log-node-degree. While the scale-free fit index (R2) will be > 0.85 with WGCNA default
requirement, how different threshold affect that linearity is not clear from Fig 1D. Also, how well can
the network be reduced by significance of correlation fit to a scale free network?
Response: 
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 Response: 
Fig. 1D (now 1E) has been included for illustrative purposes only to show some further
characteristics (in this case: degree distribution) apart from those in Table 1 of the six networks
employed for the SBM-based analysis. It can be used to appreciate the fact that the networks
reduced by requirement on significance of correlation are not optimized for it but still may exhibit a
close to linear relationship between log-frequency and log-node-degree. For clarification, we
added the scale-free fit indices obtained for each network into old Fig. 1D - now Fig. 1E. 
We also extended the description of the scale-freeness fitting procedure and approach by using
the WGCNA package (see revised Methods section). Please note that less strict correlation
thresholds than the employed here lead to networks being further away from a network with
scale-free characteristic (this is inherent to the WCGNA fitting approach as the least stringent
threshold is determined leading to a scale-free fit index of at least 0.85) and more stringent
correlation thresholds can lead to networks being closer to a scale-free network (i.e. to higher
values of R ). We give now these dependencies for the three networks in new Fig. 1D. 
Please note that reducing by a threshold on significance of correlation is a different reduction
method and it is neither expected nor intended that the resulting networks are scale-free. In order
to illustrate the relationship between the two reduction methods, we introduced new illustrations in
supplemental figure S1. Therein, 
- we show in new panel S1A that for the metabolite and mRNA layer, due to the datasets not
having NA values and thus the sample size being the same for each and every pair of metabolite or
mRNA species, the p-values of the correlation being different from zero depend monotonously on
the absolute correlation values. This is not the case for the protein dataset for which different
sample sizes may occur. Therefore, the correlation value for some interactions will be backed by
fewer data points only which leads to increased p-value despite the same correlation value.
- we show in new S1B that, for the mRNA and metabolite data layer, the scale-free fit index for
networks reduced by different significance thresholds can be directly compared to those from Fig.
1D.
- we show in new S1C how the significance threshold of correlation being different from zero
relates to the scale-free score for the protein dataset and where the four networks reduced by the
four considered significance thresholds locate therein.
>To demonstrate that SBM can provide biological insight, more detailed analysis on the
benchmark data sets could be useful. For example, what are unique and common pathways for
different breast cancer subtypes, how well are these findings consistent with existing knowledge?
Response:
We agree that a comparison of results between breast cancer subgroups to provide biological
insights into the utility of the clustering would be useful. However, our work focusses on
determining whether SBMs are suitable to represent biomolecular networks as they have not been
explored for molecular network analysis.
We indeed expect additional and complementary biological findings to what is already known with
the SBM approach. To strengthen our work, we also added some showcase examples of biological
interpretation (new Figs. 4, 5, Table 2 and Description in the text). They show that the SBM-derived
clustering can detect biological pathways known to be implicated in breast cancer according to
oncogenic signatures from MSigDB, such as extracellular matrix organization or the cell cycle (see
new Fig. 4), or fatty acid biosynthesis (Table 2). In addition, the relevance of further processes can
be predicted, e.g. the chromatin organization (new Fig. 5).
>Figure 4 shows SBM based confidence score can be used to predict the existence of an edge.
However, it is not clearly stated how the edges are determined as putatively missing or spurious.
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 However, it is not clearly stated how the edges are determined as putatively missing or spurious.
Also, the description for figure 4A is hard to understand. 
Response:
We extended the description of the edge detection by adding the following sentences in the
section ‘Assessing edge relevance by SBM-based edge confidence scores’:
‘For the six reduced networks, all edges that exist in the network were considered as ‘putatively
spurious’. Similarly, all edges that were not in the network because they had been removed from
the (fully connected) correlation-based network during the reduction procedure were considered as
‘putatively missing’.’ 
We clarified the legend to new Fig. 6A (old Fig. 4A) that now reads:
‘(A) Histograms of edge confidence scores for the best fitting SBM of the three networks reduced
by criterion on scale-freeness. Top: spurious edge confidence scores, computed for all edges
existing in the network; middle and bottom: missing edge confidence scores, computed for all
edges that were removed during the reduction procedure (middle: missing edges between nodes
with degree>0 in the reduced network, bottom: missing edges adjacent to a node of degree zero in
 the reduced network).’
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